US20150060362A1 - Apparatus for extracorporeal treatment of blood - Google Patents

Apparatus for extracorporeal treatment of blood Download PDF

Info

Publication number
US20150060362A1
US20150060362A1 US14/388,295 US201314388295A US2015060362A1 US 20150060362 A1 US20150060362 A1 US 20150060362A1 US 201314388295 A US201314388295 A US 201314388295A US 2015060362 A1 US2015060362 A1 US 2015060362A1
Authority
US
United States
Prior art keywords
pfr
fluid
check point
value
removal rate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US14/388,295
Inventor
Dominique Pouchoulin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Gambro Lundia AB
Original Assignee
Gambro Lundia AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gambro Lundia AB filed Critical Gambro Lundia AB
Priority to US14/388,295 priority Critical patent/US20150060362A1/en
Assigned to GAMBRO LUNDIA AB reassignment GAMBRO LUNDIA AB ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: POUCHOULIN, DOMINIQUE
Publication of US20150060362A1 publication Critical patent/US20150060362A1/en
Priority to US15/240,231 priority patent/US10258726B2/en
Abandoned legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/16Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/16Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
    • A61M1/1621Constructional aspects thereof
    • A61M1/1647Constructional aspects thereof with flow rate measurement of the dialysis fluid, upstream and downstream of the dialyser
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/16Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
    • A61M1/1601Control or regulation
    • A61M1/1603Regulation parameters
    • A61M1/1605Physical characteristics of the dialysate fluid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/16Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
    • A61M1/1621Constructional aspects thereof
    • A61M1/1643Constructional aspects thereof with weighing of fresh and used dialysis fluid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/34Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/34Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration
    • A61M1/3403Regulation parameters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/34Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration
    • A61M1/3403Regulation parameters
    • A61M1/341Regulation parameters by measuring the filtrate rate or volume
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/34Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration
    • A61M1/3413Diafiltration
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/34Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration
    • A61M1/342Adding solutions to the blood, e.g. substitution solutions
    • A61M1/3424Substitution fluid path
    • A61M1/3431Substitution fluid path upstream of the filter
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/34Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration
    • A61M1/342Adding solutions to the blood, e.g. substitution solutions
    • A61M1/3424Substitution fluid path
    • A61M1/3431Substitution fluid path upstream of the filter
    • A61M1/3434Substitution fluid path upstream of the filter with pre-dilution and post-dilution
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/34Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration
    • A61M1/342Adding solutions to the blood, e.g. substitution solutions
    • A61M1/3441Substitution rate control as a function of the ultrafiltration rate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/34Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration
    • A61M1/342Adding solutions to the blood, e.g. substitution solutions
    • A61M1/3441Substitution rate control as a function of the ultrafiltration rate
    • A61M1/3451Substitution rate control as a function of the ultrafiltration rate the difference in weight between both ultra-filtrate and substitution reservoir being used as control signal
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3607Regulation parameters
    • A61M1/3609Physical characteristics of the blood, e.g. haematocrit, urea
    • A61M1/361Physical characteristics of the blood, e.g. haematocrit, urea before treatment
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3621Extra-corporeal blood circuits
    • A61M1/3627Degassing devices; Buffer reservoirs; Drip chambers; Blood filters
    • A61M1/3638Degassing devices; Buffer reservoirs; Drip chambers; Blood filters with a vapour trap
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00General characteristics of the apparatus
    • A61M2205/18General characteristics of the apparatus with alarm
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00General characteristics of the apparatus
    • A61M2205/33Controlling, regulating or measuring
    • A61M2205/3331Pressure; Flow
    • A61M2205/3334Measuring or controlling the flow rate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00General characteristics of the apparatus
    • A61M2205/33Controlling, regulating or measuring
    • A61M2205/3379Masses, volumes, levels of fluids in reservoirs, flow rates
    • A61M2205/3393Masses, volumes, levels of fluids in reservoirs, flow rates by weighing the reservoir
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00General characteristics of the apparatus
    • A61M2205/50General characteristics of the apparatus with microprocessors or computers
    • A61M2205/502User interfaces, e.g. screens or keyboards
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00General characteristics of the apparatus
    • A61M2205/50General characteristics of the apparatus with microprocessors or computers
    • A61M2205/502User interfaces, e.g. screens or keyboards
    • A61M2205/505Touch-screens; Virtual keyboard or keypads; Virtual buttons; Soft keys; Mouse touches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00General characteristics of the apparatus
    • A61M2205/50General characteristics of the apparatus with microprocessors or computers
    • A61M2205/52General characteristics of the apparatus with microprocessors or computers with memories providing a history of measured variating parameters of apparatus or patient

Definitions

  • the present invention relates to an apparatus for extracorporeal treatment of blood.
  • Extracorporeal blood treatment involves removing blood from a patient, treating the blood externally to the patient, and returning the treated blood to the patient.
  • Extracorporeal blood treatment is typically used to extract undesirable matter or molecules from the patient's blood and add desirable matter or molecules to the blood.
  • Extracorporeal blood treatment is used with patients unable to effectively remove matter from their blood, such as when a patient has suffered temporary or permanent kidney failure. These patients and other patients may undergo extracorporeal blood treatment to add or remove matter to their blood, to maintain an acid/base balance or to remove excess body fluids, for example.
  • Extracorporeal blood treatment is typically accomplished by removing the blood from the patient in e.g. a continuous flow, introducing the blood into a primary chamber, also referred to as blood chamber, of a filtration unit (such as a dialyzer or an hemofilter) where the blood is allowed to flow past a semipermeable membrane.
  • a primary chamber also referred to as blood chamber
  • a filtration unit such as a dialyzer or an hemofilter
  • the semipermeable membrane selectively allows matter in the blood to cross the membrane from the primary chamber into a secondary chamber and also selectively allows matter in the secondary chamber to cross the membrane into the blood in the primary chamber, depending on the type of treatment.
  • a number of different types of extracorporeal blood treatments may be performed.
  • an ultrafiltration (UF) treatment undesirable matter is removed from the blood by convection across the membrane into the secondary chamber.
  • UF ultrafiltration
  • HF hemofiltration
  • the blood flows past the semipermeable membrane as in UF and desirable matter is added to the blood, typically by dispensing a fluid into the blood either before and/or after it passes through the filtration unit and before it is returned to the patient.
  • a hemodialysis (HD) treatment a secondary fluid containing desirable matter is introduced into the secondary chamber of the filtration unit. Undesirable matter from the blood crosses the semipermeable membrane into the secondary fluid and desirable matter from the secondary fluid may cross the membrane into the blood.
  • HDF hemodiafiltration
  • blood and secondary fluid exchange matter as in HD and, in addition, matter is added to the blood, typically by dispensing a fluid into the treated blood before its return to the patient as in HF.
  • blood treatment apparatus presenting infusion lines for supplying fluid upstream or downstream the filtration unit, a fresh dialysis liquid line for supplying liquid to the dialysate chamber of the filtration unit, and a waste line receiving spent dialysis fluid and ultrafiltered fluid from filtration unit.
  • means for generating a flow rate is acting, such as a peristaltic pump which is rotated under the supervision of a control unit.
  • fluid containers supply fluid to the infusion lines and to the dialysate line, while a waste container or a waste handling system receives the spent liquid from the waste line.
  • scales are used to weigh the fluid containers and to provide signals used by the control unit to control the pumps or other actuators on the fluid lines so that the apparatus achieves the fluid removal rate set by the user, and—depending upon the apparatus—any other rates through each line.
  • each of the above lines receives fluid from a respective container which, in use, is associated to a respective scale and cooperates with a respective pump.
  • a user interface allows an operator entering the patient fluid removal rate and the fluid flow rates of each of the substitution lines and dialysate line such that the apparatus is capable of continuously keep under control the amount of fluid infused, the amount of fluid flowing through the dialysate line and the fluid loss rate.
  • an object of the invention an apparatus which is able to take into account the effective portions of the treatment procedure, adapting certain set-up parameters to account for machine stops, therapy delivery interruptions, machine downtimes.
  • An auxiliary object is an apparatus able to control patient fluid removal rate across long treatments, without compromising the operating philosophy of an intensive care apparatus.
  • Another object is an apparatus capable of operating in a safe manner.
  • Another object is to automatically ascertain whether certain prescription targets cannot be achieved and inform the operator accordingly.
  • a 1st aspect relates to an apparatus for extracorporeal treatment of blood comprising:
  • control procedure further comprises, after calculation of said updated value (Q pfr — new ), controlling the ultrafiltration actuator after the check point as a function of said updated value (Q pfr — new ) for the fluid removal rate.
  • a new Q eff is calculated using (e.g. in formulas (1), (2) or (3)) Q pfr — new in place of Q pfr — set ; and then used to control the ultrafiltration actuator, namely the waste pump positioned on the effluent line exiting from the second chamber.
  • control procedure further comprises controlling the ultrafiltration actuator, after the check point and until either a subsequent check point as a function of said updated value (Q pfr — new ) for the fluid removal rate.
  • control unit ( 10 ) is configured for re-executing said control procedure at a plurality of check points (Ti) during patient treatment, said plurality of check points being one or more in the group of:
  • control procedure comprises:
  • control procedure comprises calculating the updated value (Q pfr — new ) for said fluid removal rate (Q pfr ) at check point (T i ) according to the formula:
  • V pfr — removed is the value of the fluid removed from the patient over time period (T retro ) preceding a check point (T i );
  • each reference time interval ( ⁇ T) is of prefixed duration, beginning at prefixed start times (T 00 ; T 00 + ⁇ T; . . . ; T 00 +k ⁇ T) and ending at prefixed ending times (T 00 + ⁇ T; T 00 +2 ⁇ T; . . . ; T 00 +(k+1) ⁇ T).
  • control procedure comprises calculating the updated value (Q pfr — new ) for said fluid removal rate (Q pfr ) at check point (T i ) comprised between a start time (T 00 +k ⁇ T) and an end time T 00 +(k+1) ⁇ T according to the formula:
  • control procedure comprises:
  • the effective portion (T eff ) is calculated reducing the duration of said the time period following check point (T i ) by a quantity linked to the number of bag changes expected in the next time period.
  • the effective portion (T eff ) is calculated reducing the duration of said the time period following check point (T i ) by a quantity linked to down times caused by alarm conditions.
  • the effective portion (T eff ) is calculated reducing the duration of said the time period following check point (T i ) by a quantity 11 linked to down times caused by alarm conditions if the duration of the time period (T prosp ) following the check point (T i ) is greater than a prefixed duration, such as grater than 30 mins or grater than 60 mins.
  • control unit is configured for receiving the set value (Q pfr — set ) for patient fluid removal rate from an operator's input or from a remote source communicatively connected to the control unit or for pre-storing said set value.
  • the apparatus further comprises a user interface ( 12 ) connected to the control unit ( 10 ), said control unit being configured to execute the following before executing the control procedure:
  • the apparatus further comprises a pre-dilution fluid line ( 15 ) connected to the blood withdrawal line and a pre-dilution pump ( 18 ) connected to the control unit ( 10 ) and acting on the pre-dilution line for regulating the flow through said pre-dilution fluid.
  • the apparatus further comprises a post-dilution fluid line ( 25 ) connected to the blood return line and a post-dilution pump ( 27 ) connected to the control unit ( 10 ) and acting on the post-dilution line for regulating the flow through said post-dilution fluid line.
  • the apparatus further comprises a dialysis fluid line ( 19 ) connected to the inlet of the secondary chamber and a dialysis fluid pump ( 21 ) connected to the control unit ( 10 ) and acting on the dialysis liquid line for regulating the flow through said dialysis fluid line.
  • the apparatus further comprises a pre-blood pump infusion line ( 22 ) connected to the blood withdrawal line in a region of this latter which is positioned in use upstream the blood pump, a pre-blood infusion pump ( 24 ) connected to the control unit ( 10 ) and acting on the pre-blood pump infusion line for regulating the flow through said pre-blood pump infusion line.
  • said control unit is configured to receive set values for one or more fluid flow rates selected in the group including a fluid flow rate (Q eff ) through the effluent line ( 13 ), a fluid flow rate (Q rep , Q pbp ) through the infusion fluid line ( 15 , 22 , 25 ), a fluid flow rate (Q dial ) through the dialysis liquid fluid line ( 19 ), in addition to said fluid removal rate (Q pfr ) from the patient and to control said pumps and said actuator based on the set values for said one or more fluid flow rates and for said fluid removal rate (Q pfr ) from the patient.
  • the apparatus further comprises a syringe pump connected to the blood withdrawal line and/or a syringe pump connected to the blood return line
  • said control unit is configured to receive set values for the fluid flow rates through the syringe pump or syringe pumps and to control said infusion pumps, said dialysis pump and said ultrafiltration actuator based on the set values for said one or more fluid flow rates, for said fluid removal rate (Q pfr ) from the patient, and on the set flow rates for the syringe pumps.
  • each line is controlled based on the respective set flow rate, except for the effluent line where the ultrafiltration actuator (e.g. a pump) is controlled based on the Q eff calculated using formulas (1), (2) or (3) described below in the detailed description, adopting Q pfr — new in place of Q pfr — set .
  • control procedure comprises requesting the user, optionally via the user interface, to confirm that the calculated updated value (Q pfr — new ) for said fluid removal rate (Q pfr ) is acceptable before using it for controlling the ultrafiltration actuator.
  • control procedure comprises comparing the calculated updated value (Q pfr — new ) for said fluid removal rate (Q pfr ) against a maximum threshold value before using it for controlling the ultrafiltration actuator.
  • control procedure comprises executing one or more of the following safety checks:
  • the ultrafiltration actuator comprises a waste pump ( 17 ) acting on the effluent conduit ( 13 ), this latter leading to a waste container ( 14 ) configured for collecting fluid extracted from the secondary chamber ( 4 );
  • the apparatus comprises one or more of the following containers:
  • the apparatus comprises the following containers:
  • a 27 th aspect relates to a process for controlling an apparatus for extracorporeal treatment of blood, the apparatus being of the type comprising: a filtration unit ( 2 ) having a primary chamber ( 3 ) and a secondary chamber ( 4 ) separated by a semi-permeable membrane ( 5 ); a blood withdrawal line ( 6 ) connected to an inlet of the primary chamber ( 3 ), and a blood return line ( 7 ) connected to an outlet of the primary chamber ( 4 ) said blood lines being designed to be connected to a patient cardiovascular system; a blood pump ( 11 ) for controlling the flow of blood through the blood lines ( 6 , 7 ); an effluent fluid line ( 13 ) connected to an outlet of the secondary chamber ( 4 ); an ultrafiltration actuator connected to the effluent fluid line ( 13 ) and configured to cause a transfer of fluid from the primary ( 3 ) to the secondary chamber ( 4 ).
  • the process which may for instance be executed by a control unit, includes the steps of:
  • control procedure further comprises, after calculation of said updated value (Q pfr — new ), controlling the ultrafiltration actuator after the check point as a function of said updated value (Q pfr — new ) for the fluid removal rate.
  • a new Q eff is calculated using (e.g. in formulas (1), (2) or (3)) Q pfr — new in place of Q pfr — set ; and then used to control the ultrafiltration actuator, namely the waste pump positioned on the effluent line exiting from the second chamber.
  • control procedure further comprises controlling the ultrafiltration actuator, after the check point and until either a subsequent check point as a function of said updated value (Q pfr — new ) for the fluid removal rate.
  • a 30 th aspect comprising re-executing said control procedure at a plurality of check points (Ti) during patient treatment, said plurality of check points being one or more in the group of:
  • control procedure comprises:
  • control procedure comprises calculating the updated value (Q pfr — new ) for said fluid removal rate (Q pfr ) at check point (T i ) according to the formula:
  • each reference time interval ( ⁇ T) is of prefixed duration, beginning at prefixed start times (T 00 ; T 00 + ⁇ T; . . . ; T 00 +k ⁇ T) and ending at prefixed ending times (T 00 + ⁇ T; T 00 +2 ⁇ T; . . . ; T 00 +(k+1) ⁇ T).
  • control procedure comprises calculating the updated value (Q pfr — new ) for said fluid removal rate (Q pfr ) at check point (T i ) comprised between a start time (T 00 +k ⁇ T) and an end time T 00 +(k+1) ⁇ T according to the formula:
  • control procedure comprises:
  • the effective portion (T eff ) is calculated reducing the duration of said the time period following check point (T i ) by a quantity linked to the number of bag changes expected in the next time period.
  • the effective portion (T eff ) is calculated reducing the duration of said the time period following check point (T i ) by a quantity linked to down times caused by alarm conditions.
  • the effective portion (T eff ) is calculated reducing the duration of said the time period following check point (T i ) by a quantity 11 linked to down times caused by alarm conditions if the duration of the time period (T prosp ) following the check point (T i ) is greater than a prefixed duration, such as grater than 30 mins or grater than 60 mins.
  • the process includes receiving the set value (Q pfr — set ) for patient fluid removal rate from an operator's input or from a remote source communicatively connected to the control unit or for pre-storing said set value.
  • the process comprises executing the following steps before executing the control procedure:
  • the apparatus is of the type disclosed in any one of aspects from the 15 th to the 20 th .
  • control procedure comprises comparing the calculated updated value (Q pfr — new ) for said fluid removal rate (Q pfr ) against a maximum threshold value before using it for controlling the ultrafiltration actuator.
  • control procedure comprises executing one or more of the following safety checks:
  • the ultrafiltration actuator comprises a waste pump ( 17 ) acting on the effluent conduit ( 13 ), this latter leading to a waste container ( 14 ) configured for collecting fluid extracted from the secondary chamber ( 4 );
  • the apparatus comprises one or more of the following containers:
  • a data carrier including instructions executable by a control unit of a blood treatment (for instance of the blood treatment device of any one of aspects from 1 st to 26 th apparatus) is provided.
  • the instructions are configured such that, when executed by the control unit, they cause execution of the process according to any one of the preceding aspects from 27 th to 45 th .
  • the data carrier may be any support suitable for storing data, such as by way of non-limiting example: a RAM, a ROM, an EPROM, an optical or a magnetic disc, an electromagnetic wave, a mass memory storage device such as an Hard Disk or a flash memory bank.
  • FIG. 1 shows a schematic diagram of a blood treatment apparatus according to one aspect of the invention
  • FIG. 2 shows a schematic diagram of an alternative embodiment of a blood treatment apparatus according to another aspect of the invention
  • FIG. 3 shows a schematic diagram of a further alternative embodiment of a blood treatment apparatus according to another aspect of the invention
  • FIG. 4 shows a block diagram of a procedure executable by a control unit according to a further aspect of the invention
  • FIG. 5 graphically shows a first example of a control procedure according to aspects of the invention
  • FIG. 6 graphically shows a second example of a control procedure according to aspects of the invention.
  • FIG. 7 graphically shows a third example of a control procedure according to aspects of the invention.
  • FIGS. 1 , 2 and 3 show exemplifying, and non limiting, embodiments of an apparatus for extracorporeal treatment of blood. Note that same components are identified by same reference numerals in FIGS. 1-3 .
  • FIG. 1 shows an apparatus 1 designed for delivering any one of treatments like hemodialysis, hemofiltration, hemodiafiltration, and ultrafiltration.
  • the apparatus 1 comprises a filtration unit 2 having a primary chamber 3 and a secondary chamber 4 separated by a semi-permeable membrane 5 ; depending upon the treatment, the membrane of the filtration unit may be selected to have different properties and performances.
  • a blood withdrawal line 6 is connected to an inlet of the primary chamber 3
  • a blood return line 7 is connected to an outlet of the primary chamber 3 .
  • the blood withdrawal line 6 and the blood return line 7 are connected to a needle or to a catheter or other access device (not shown) which is then placed in fluid communication with the patient vascular system, such that blood can be withdrawn through the blood withdrawal line, flown through the primary chamber and then returned to the patient's vascular system through the blood return line.
  • An air separator such as a bubble trap 8 may be present on the blood return line; moreover, a safety clamp 9 controlled by a control unit 10 may be present on the blood return line downstream the bubble trap 8 .
  • a bubble sensor 8 a for instance associated to the bubble trap 8 or coupled to a portion of the line 7 between bubble trap 8 and clamp 9 may be present: if present, the bubble sensor is connected to the control unit 10 and sends to the control unit signals for the control unit to cause closure of the clamp 9 in case one or more bubbles above certain safety thresholds are detected.
  • the blood flow through the blood lines is controlled by a blood pump 11 , for instance a peristaltic blood pump, acting either on the blood withdrawal line (as shown in FIG.
  • An operator may enter a set value for the blood flow rate Q B through a user interface 12 and the control unit 10 , during treatment, is configured to control the blood pump based on the set blood flow rate.
  • the control unit may comprise a digital processor (CPU) and memory (or memories), an analogical type circuit, or a combination thereof as explained in greater detail in below section dedicated to the ‘control unit’.
  • An effluent fluid line 13 is connected, at one end, to an outlet of the secondary chamber 4 and, at another end, to an effluent fluid container 14 collecting the fluid extracted from the secondary chamber.
  • the apparatus of FIG. 1 also presents a pre-dilution fluid line 15 connected to the blood withdrawal line: this line 15 supplies replacement fluid from an infusion fluid container 16 connected at one end of the pre-dilution fluid line.
  • the apparatus of FIG. 1 may include a post-dilution fluid line (not shown in FIG. 1 ) connecting an infusion fluid container to the blood return line.
  • the apparatus of FIG. 1 may include both a pre-dilution and a post infusion fluid line: in this case each infusion fluid line may be connected to a respective infusion fluid container or the two infusion fluid lines may receive infusion fluid from a same source of infusion fluid such as a same infusion fluid container.
  • An effluent fluid pump 17 operates on the effluent fluid line under the control of said control unit 10 to regulate the flow rate Q eff across the effluent fluid line.
  • an infusion pump 18 operates on the infusion line 15 to regulate the flow rate Q rep through the infusion line.
  • each infusion line may cooperate with a respective infusion pump.
  • the apparatus of FIG. 1 further includes a dialysis fluid line 19 connected at one end with a dialysis fluid container 20 and at its other end with the inlet of the secondary chamber 4 of the filtration unit.
  • a dialysis liquid pump 21 works on the dialysis liquid fluid line under the control of said control unit 10 , to supply fluid from the dialysis liquid container to the secondary chamber at a flow rate Q dial .
  • the dialysis fluid pump 21 , the infusion fluid pump 15 and the effluent fluid pump 17 are operatively connected to the control unit 10 which controls the pumps as it will be in detail disclosed herein below.
  • the control unit 10 is also connected to the user interface 12 , for instance a graphic user interface, which receives operator's inputs and displays the apparatus outputs.
  • the graphic user interface 12 may include a touch screen, a display screen and hard keys for entering user's inputs or a combination thereof.
  • FIG. 2 shows an alternative apparatus 1 where the same components described for the embodiment of FIG. 1 are also presents and are identified by same reference numerals and thus not described again.
  • the apparatus 1 shown in FIG. 2 may present a further infusion line 22 connected, at one end, with a portion 6 a of the blood withdrawal line 6 positioned upstream the blood pump 11 and, at its other end, with a further infusion fluid container 23 , which for instance may contain a drug, or a regional anticoagulant such as a citrate solution, or a nutrients solution or other.
  • This further infusion line is herein referred to as pre-blood pump infusion line 22 .
  • a pump 24 for instance a peristaltic pump controlled by control unit 10 , may act on a segment of the pre-blood pump infusion line to regulate a pre-blood pump infusion rate Q pbp .
  • the apparatus of FIG. 2 may also present a post-dilution line 25 (represented with dashed line) connected at one end with a further container 26 of infusion liquid and connected at its other end with the blood return line 7 .
  • a further pump 27 for instance a peristaltic pump, may act under the control of control unit 10 on the post-dilution line 25 .
  • FIG. 3 A third embodiment is shown in FIG. 3 .
  • the apparatus of FIG. 3 is an ultrafiltration apparatus comprising a filtration unit 2 (in this case an ultrafilter) having a primary chamber 3 and a secondary chamber 4 separated by a semi-permeable membrane 5 .
  • a blood withdrawal line 6 is connected to an inlet of the primary chamber 3
  • a blood return line 7 is connected to an outlet of the primary chamber 3 .
  • the blood withdrawal line 6 and the blood return line 7 are connected in use to a needle or to a catheter or other access device (not shown) which is then placed in fluid communication with the patient vascular system, such that blood can be withdrawn through the blood withdrawal line, flown through the primary chamber and then returned to the patient's vascular system through the blood return line.
  • An air separator such as a bubble trap 8 may be present on the blood return line; moreover, a safety clamp 9 controlled by a control unit 10 may be present on the blood return line downstream the bubble trap 8 .
  • a bubble sensor 8 a for instance associated to the bubble trap 8 or coupled to a portion of the line 7 between bubble trap 8 and clamp 9 may be present: if present, the bubble sensor is connected to the control unit 10 and sends to the control unit signals for the control unit to cause closure of the clamp 9 in case one or more bubbles above certain safety thresholds are detected.
  • the blood flow through the blood lines is controlled by a blood pump 11 , for instance a peristaltic blood pump, acting either on the blood withdrawal line (as shown in FIG.
  • An operator may enter a set value for the blood flow rate Q B through a user interface 12 and the control unit 10 , during treatment, is configured to control the blood pump based on the set blood flow rate.
  • the control unit may comprise a digital processor (CPU) and memory (or memories), an analogical type circuit, or a combination thereof as explained in greater detail in below section dedicated to the ‘control unit’.
  • An effluent fluid line 13 is connected, at one end, to an outlet of the secondary chamber 4 and, at another end, to an effluent fluid container 14 collecting the fluid extracted from the secondary chamber.
  • An effluent fluid pump 17 operates on the effluent fluid line under the control of said control unit 10 to regulate the flow rate Q eff across the effluent fluid line.
  • the control unit 10 is also connected to the user interface 12 , for instance a graphic user interface, which receives operator's inputs and displays the apparatus outputs.
  • the graphic user interface 12 may include a touch screen, a display screen and hard keys for entering user's inputs or a combination thereof.
  • an ultrafiltration actuator comprising the effluent fluid pump 17 , is inserted into the effluent fluid line 13 and configured to cause a transfer of fluid from the primary 3 to the secondary chamber 4 ;
  • the control unit may drive the dialysis liquid pump 21 , the infusion pump 18 and the effluent pump 17 such that Q eff is equal to Q dial +Q rep1 +Q pfr ; in other words, the control unit drives the mentioned pumps so that the total flow rate flowing through the effluent line is made equal to the sum of the flow rate through the fresh dialysis liquid line, the flow rate through the replacement fluid line and the patient fluid removal rate which is to be imposed on the patient.
  • FIG. 1 the control unit may drive the dialysis liquid pump 21 , the infusion pump 18 and the effluent pump 17 such that Q eff is equal to Q dial +Q rep1 +Q pfr ; in other words, the control unit drives the mentioned pumps so that the total flow rate flowing through the effluent line is made equal to the sum of the flow rate
  • control unit may drive the dialysis liquid pump 21 , the infusion pumps 18 and 27 , the pre-blood pump infusion pump 24 and the effluent pump 17 such that Q eff is made equal to Q dial +Q rep1 +Q rep2 +Q pbp +Q pfr ; in the embodiment of FIG. 3 , the flow Q eff equals Q pfr as there is no dialysate or infusion line.
  • the extracorporeal blood treatment apparatus 1 e.g. the apparatus 1 of FIGS.
  • syringe pumps may include one or more syringe pumps: for instance a syringe pump connected to the blood withdrawal line 6 and a syringe pump connected to the blood return line 7 ; of course only one syringe may be used either connected to line 6 or to line 7 .
  • Q eff would be controlled to account for the flow rate delivered by said syringe pump(s).
  • the apparatus 1 also comprises a first scale 33 operative for providing weight information W 1 relative to the amount of the fluid collected in the effluent fluid container 14 ; a second scale 34 operative for providing weight information W 2 relative to the amount of the fluid supplied from the infusion fluid container 16 ; a third scale 35 operative for providing weight information W 3 relative to the amount of the fluid supplied from dialysis fluid container 20 .
  • a first scale 33 operative for providing weight information W 1 relative to the amount of the fluid collected in the effluent fluid container 14
  • a second scale 34 operative for providing weight information W 2 relative to the amount of the fluid supplied from the infusion fluid container 16
  • a third scale 35 operative for providing weight information W 3 relative to the amount of the fluid supplied from dialysis fluid container 20 .
  • a respective fourth and fifth scales 36 and 37 could be present to provide weight information W 4 , W 5 relative to the amount of fluid supplied from infusion container 23 and from infusion container 26 .
  • a single scale 33 is present which is operative for providing weight information relative to the amount of the fluid collected in the effluent fluid container 14 .
  • the scales are all connected to the control unit 10 and provide said weight information W i for the control unit to determine the actual quantity of fluid in each container as well as the actual flow rate of fluid supplied by or received in each container.
  • the control unit may also be configured to receive weight information W i from the first scale and, depending upon the selected treatment and type of apparatus, from one or more of the other the scales and to control the flow rate through the effluent fluid line, the infusion fluid line (if present), the dialysis fluid line (if present) by controlling the respective pumps based on said weight information W i , and on initial set values.
  • all containers 14 , 16 , 20 , 23 may be disposable plastic containers, for instance bags which are hang on a support carried by the respective scale. All lines and the filtration unit may also be plastic disposable components which may be mounted at the beginning of the treatment session and then disposed of at the end of the treatment session. Pumps, e.g. peristaltic pumps, have been described as means for regulating fluid flow through each of the lines; however it should be noted that other flow regulating means could alternatively be adopted such as for example valves or combinations of valves and pumps.
  • the scales may comprise piezoelectric sensors, or strain gauges, or spring sensors, or any other type of transducer able to sense forces applied thereon.
  • volumetric sensors for determining flow rates or combinations of mass and volumetric sensors may alternatively be adopted.
  • the control unit 10 is configured to control the ultrafiltration actuator (e.g. by controlling at least the effluent pump 17 ) based on a set value Q pfr — set and to control the other pumps (such as pumps 18 , 21 , 24 , 27 and the syringe(s)) if present) based on set values initially set by an operator or pre-stored in the machine or received from a source external to the machine; for instance, with reference to FIG.
  • the control unit 10 may receive (step 100 ) set values for one or more of the flow rates Q rep — set to be imposed through the infusion lines (when present), the set value Q dial — set to be imposed through the dialysis liquid line (when present) and the set value Q pfr — set for the patient fluid removal rate which is a desired value for the rate of fluid removal from the patient which is to be maintained during treatment.
  • the control unit 10 would be only receive the set value for the patient fluid removal rate Q pfr — set and would be configured to control the ultrafiltration actuator based on said set value Q pfr — set . Then, the control unit may calculate the value Q eff — set (step 101 ):
  • the control unit is configured to calculate the set value Q pbp — set as a function of the set blood flow rate Q B — set .
  • the set flow rate is considered in equation (1) above and added at second member as follows:
  • Q eff — set Q dial — set +Q rep — set +Q pbp — set +Q pfr — set (2).
  • equation (2) becomes:
  • the control unit uses the calculated Q eff — set as value of the effluent flow rate Q eff (step 101 a ) which is used to control the flow of fluid through the effluent line.
  • the control unit may control (step 102 ) each of the infusion pumps and the dialysis pump such that the actual flow rate matches the respective set flow rate and may control the effluent pump 17 (or ultrafiltration actuator) such that the actual flow rate through the effluent line matches the calculated value Q eff — set .
  • Q eff — set may be used as Q eff to control the ultrafiltration actuator, e.g. the effluent pump 17 in the examples of FIGS. 1-3 .
  • the control unit 10 is also configured to execute at check points T i (step 103 ) during patient treatment a control procedure comprising the steps 104 , 105 and 106 as schematically shown in the flow chart of FIG. 4 .
  • the control unit 10 may be configured for re-executing the control procedure at a plurality of check points T i during patient treatment: various criteria may be adopted to identify the check points T i .
  • the control procedure may be repeated at periodic check points or at check points separated by time intervals following a prescribed rule (i.e. the time intervals between consecutive check points may not be all equal but nevertheless follow a prescribed rule).
  • control procedure may be activated at check points triggered by specific events, such as a downtime of the machine due to a bag change or other reason, setting of a new set value Q pfr — set for patient fluid removal rate, or setting of a new set value for any one of the flow rates Q rep — set , Q pbp — set through the infusion lines (when present), the set value Q dial — set to be imposed through the dialysis liquid line (when present).
  • specific events such as a downtime of the machine due to a bag change or other reason, setting of a new set value Q pfr — set for patient fluid removal rate, or setting of a new set value for any one of the flow rates Q rep — set , Q pbp — set through the infusion lines (when present), the set value Q dial — set to be imposed through the dialysis liquid line (when present).
  • control procedure comprises the following steps.
  • Step 104 receiving one check information selected in the group of:
  • T i this value may be calculated or measured by the scale or scales.
  • Step 105 calculating an updated value Q pfr — new for said fluid removal rate Q pfr as a function of said set value for a fluid removal rate Q pfr — set and of said check information.
  • the new value Q pfr — new is higher than the set value Q pfr — set .
  • there may be cases e.g. if there is a flow delivery problem on dialysate or replacement
  • the new value Q pfr — new is smaller than the set value Q pfr — set .
  • Steps 106 after calculation of said updated value Q pfr — new , the control unit is configured for calculating a new Q eff for then returning to step 102 .
  • control unit controls the ultrafiltration actuator (and the other pumps if present as above described in connection with step 102 ) as a function of said new Q eff and therefore as a function of the updated value Q pfr — new of the fluid removal rate.
  • the control may use one of algorithms (1) or (2) or (3) depending upon the apparatus configuration, adopting Q pfr — new in place of Q pfr — set
  • the control with the updated value may start immediately after the check point and last until a subsequent check point.
  • FIG. 5 shows a first example of implementation of the control procedure which has been described herein above.
  • control procedure comprises:
  • the ‘check point’ T i when instantaneous Q pfr — new is computed may be done:
  • T retro and T prosp may be in the range of 1 to 6-8 hours.
  • control unit 10 will control the pump 17 based on the new calculated value of 102.5 ml/h during the 4 h following the first check point.
  • FIG. 6 shows a second example of implementation of the control procedure which has been described herein above.
  • the procedure aims at achieving the most accurate Patient Fluid Removal over predefined time periods.
  • periods of constant duration ⁇ T are prefixed, beginning at a prefixed time T00:
  • control unit 10 aims at delivering the exact patient fluid removal prescription over predefined time windows, such as matching with staff shifts or simply ‘round hours’ (13:00, 14:00, 15:00 . . . ).
  • the ‘check point’ T i when instantaneous Q pfr — new is computed may be done:
  • control procedure comprises calculating the updated value Q pfr — new for said fluid removal rate Q pfr at check point T i comprised between a start time T 00 +k ⁇ T and an end time T 00 +(k+1) ⁇ T according to the formula:
  • T prosp ( T 00 +( k +1) ⁇ T ) ⁇ T i
  • T prosp ( T 00 +( k +1) ⁇ T ) ⁇ T
  • control unit 10 will control the pump 17 based on the new calculated value of 106.0 ml/h during the 1.5 h following the check point at 10.30 in order to achieve the desired patient fluid removal by 12.00.
  • Performance of the previous algorithms may be further enhanced when anticipating ‘future’ down times.
  • control procedure described above may comprises a step of determining an effective portion T eff of said the time period T prosp or (T 00 +(k+1) ⁇ T) ⁇ T i following the check point T i . Then, the updated value Q pfr — new for the fluid removal rate Q pfr is calculated by the control unit using T eff in place of the duration the time period following the check point T i , i.e. in place of Tprosp or (T 00 +(k+1) ⁇ T) ⁇ T i .
  • Example 2 The following example is similar to Example 2 (reference is made to FIGS. 3 and 6 ) and shows calculation and use of the effective portion T eff which is determined in this case by reducing the duration of the time period following check point T i by a first quantity linked to a bag change average time expected to be spent in the next time period and by a second quantity linked to down times caused by alarm conditions.
  • T eff where T prosp becomes small (e.g. ⁇ 30 minutes) the predictive term due to alarms may be ignored.
  • control unit 10 will control the pump 17 based on the new calculated value of 112.1 ml/h during the 1.5 h following the check point at 10.30 in order achieve the most accurate delivery of the desired patient fluid removal over the time periods [4:00; 8:00] and [8:00; 12:00]. According to the criteria used for deciding on check points, this flow rate will be further adjusted at least twice before the current time period [8:00; 12:00] is elapsed (2 planned bag changes).
  • FIG. 7 shows another example of implementation of the control procedure which has been described herein above.
  • the procedure aims at achieving the most accurate Patient Fluid Removal over predefined time periods.
  • the time periods are defined around the clock and may be of different durations.
  • control unit 10 aims at delivering the exact patient fluid removal prescription over each predefined time window, such as matching with staff shifts.
  • the ‘check point’ Ti when instantaneous Q pfr — new is computed may be done:
  • control procedure comprises calculating the updated value Q pfr — new for said fluid removal rate Q pfr at check point T i comprised between a start time T k and an end time T k+1 according to the formula:
  • control unit 10 will control the pump 17 based on the new calculated value of 108.3 ml/h from the 11:12 check point in order to achieve the desired patient fluid removal by 13.00.
  • the apparatus described above may include one or more of the following safety features.
  • safety features below disclosed may play an important role after a therapy interruption of several tens of minutes, e.g. change of the disposable tubing or substitution of filter set associated with the apparatus, temporary patient disconnection due to any reason. These situations may lead to relatively high Qpfr_new values which if actuated with no safety checks might lead to problems for the treated patient.
  • the control procedure executed by the control unit 10 may include a step of requesting the user, for instance via the user interface 12 , to confirm that the calculated updated value Q pfr — new for said fluid removal rate Q pfr is acceptable before using it for controlling the ultrafiltration actuator.
  • the control unit would in this case wait for a user confirmation before actually using the calculated updated value Q pfr — new for controlling pump 17 .
  • the control procedure may also include comparing the calculated updated value Q pfr — new for said fluid removal rate (Q pfr ) against a maximum threshold value before using it for controlling the ultrafiltration actuator.
  • a maximum threshold value For example, a lower value is used or an alarm condition is generated or a warning signal sent to the operator e.g. via user interface 12 .
  • the control procedure may comprise executing one or more of the following further safety checks:
  • the update value Q pfr — new is used for controlling the ultrafiltration actuator.
  • control unit is may also be configured for allowing setting of one or more boundary conditions in order to customize the apparatus to specific needs or patients.
  • control unit may comprise a digital processor (CPU) with memory (or memories), an analogical type circuit, or a combination of one or more digital processing units with one or more analogical processing circuits.
  • CPU digital processor
  • memory or memories
  • an analogical type circuit or a combination of one or more digital processing units with one or more analogical processing circuits.
  • the control unit is “configured” or “programmed” to execute certain steps: this may be achieved in practice by any means which allow configuring or programming the control unit.
  • one or more programs are stored in an appropriate memory: the program or programs containing instructions which, when executed by the control unit, cause the control unit to execute the steps described or claimed in connection with the control unit.
  • the circuitry of the control unit is designed to include circuitry configured, in use, to process electric signals such as to execute the control unit steps herein disclosed.

Abstract

An apparatus for extracorporeal treatment of blood (1) comprising a filtration unit (2), a blood withdrawal line (6), a blood return line (7), an effluent fluid line (13), a pre and/or post-dilution fluid line (15, 25) connected to the blood withdrawal line, and a dialysis fluid line. Pumps (17, 18, 21, 22, 27) act on the fluid lines for regulating the flow of fluid. A control unit (10) is configured to periodically calculate a new value for the patient fluid removal rate to be imposed on an ultrafiltration actuator in order to keep a predefined patient fluid removal rate across a reference time interval irrespective of machine down times.

Description

  • The present invention relates to an apparatus for extracorporeal treatment of blood.
  • Extracorporeal blood treatment involves removing blood from a patient, treating the blood externally to the patient, and returning the treated blood to the patient. Extracorporeal blood treatment is typically used to extract undesirable matter or molecules from the patient's blood and add desirable matter or molecules to the blood. Extracorporeal blood treatment is used with patients unable to effectively remove matter from their blood, such as when a patient has suffered temporary or permanent kidney failure. These patients and other patients may undergo extracorporeal blood treatment to add or remove matter to their blood, to maintain an acid/base balance or to remove excess body fluids, for example.
  • Extracorporeal blood treatment is typically accomplished by removing the blood from the patient in e.g. a continuous flow, introducing the blood into a primary chamber, also referred to as blood chamber, of a filtration unit (such as a dialyzer or an hemofilter) where the blood is allowed to flow past a semipermeable membrane. The semipermeable membrane selectively allows matter in the blood to cross the membrane from the primary chamber into a secondary chamber and also selectively allows matter in the secondary chamber to cross the membrane into the blood in the primary chamber, depending on the type of treatment.
  • A number of different types of extracorporeal blood treatments may be performed. In an ultrafiltration (UF) treatment, undesirable matter is removed from the blood by convection across the membrane into the secondary chamber. In a hemofiltration (HF) treatment, the blood flows past the semipermeable membrane as in UF and desirable matter is added to the blood, typically by dispensing a fluid into the blood either before and/or after it passes through the filtration unit and before it is returned to the patient. In a hemodialysis (HD) treatment, a secondary fluid containing desirable matter is introduced into the secondary chamber of the filtration unit. Undesirable matter from the blood crosses the semipermeable membrane into the secondary fluid and desirable matter from the secondary fluid may cross the membrane into the blood. In a hemodiafiltration (HDF) treatment, blood and secondary fluid exchange matter as in HD, and, in addition, matter is added to the blood, typically by dispensing a fluid into the treated blood before its return to the patient as in HF.
  • Specific blood treatment apparatus have been developed for the treatment of acute patients mainly because:
      • it is not known how long these patients will suffer from kidney insufficiency; thus, the total treatment time is a priori unknown and, as such, it may not be used as setup parameter;
      • in fact, intensive care apparatus used for treating acute patient are designed to request flow rate information as setup parameters;
      • moreover, acute patients need relatively long treatment sessions, typically lasting several days, during which the blood treatment apparatus is a master piece of the patient fluid balance management, allowing for accurate balancing of the multiple infusions generally present (drugs, fluids, nutrition);
      • furthermore, acute patients often need to be treated in emergency situations, thus apparatus for acute treatment shall be characterized by easy and safe set up procedures.
  • In this situation, blood treatment apparatus have been developed presenting infusion lines for supplying fluid upstream or downstream the filtration unit, a fresh dialysis liquid line for supplying liquid to the dialysate chamber of the filtration unit, and a waste line receiving spent dialysis fluid and ultrafiltered fluid from filtration unit. In correspondence of each of the above lines, means for generating a flow rate is acting, such as a peristaltic pump which is rotated under the supervision of a control unit. Moreover, fluid containers supply fluid to the infusion lines and to the dialysate line, while a waste container or a waste handling system receives the spent liquid from the waste line. Typically, scales are used to weigh the fluid containers and to provide signals used by the control unit to control the pumps or other actuators on the fluid lines so that the apparatus achieves the fluid removal rate set by the user, and—depending upon the apparatus—any other rates through each line. In more sophisticated solutions, each of the above lines receives fluid from a respective container which, in use, is associated to a respective scale and cooperates with a respective pump. A user interface allows an operator entering the patient fluid removal rate and the fluid flow rates of each of the substitution lines and dialysate line such that the apparatus is capable of continuously keep under control the amount of fluid infused, the amount of fluid flowing through the dialysate line and the fluid loss rate.
  • Although the above solution results in efficient apparatus able to perform all necessary treatments and to accurately control the flows, the applicant has found ways to further improve known blood treatment apparatuses.
  • It is an object of the present invention to render available a blood treatment apparatus suitable for intensive care applications which may be automatically able to account for down times or interruption in the treatment delivery.
  • More in detail, it is an object of the invention an apparatus which is able to take into account the effective portions of the treatment procedure, adapting certain set-up parameters to account for machine stops, therapy delivery interruptions, machine downtimes.
  • An auxiliary object is an apparatus able to control patient fluid removal rate across long treatments, without compromising the operating philosophy of an intensive care apparatus.
  • Another object is an apparatus capable of operating in a safe manner.
  • Another object is to automatically ascertain whether certain prescription targets cannot be achieved and inform the operator accordingly.
  • SUMMARY
  • At least one of the above objects is substantially reached by an apparatus according to one or more of the appended claims.
  • Apparatus and processes for the extracorporeal treatment of blood according to aspects of the invention are here below described.
  • A 1st aspect relates to an apparatus for extracorporeal treatment of blood comprising:
    • a filtration unit (2) having a primary chamber (3) and a secondary chamber (4) separated by a semi-permeable membrane (5); a blood withdrawal line (6) connected to an inlet of the primary chamber (3), and a blood return line (7) connected to an outlet of the primary chamber (4) said blood lines being designed to be connected to a patient cardiovascular system; a blood pump (11) for controlling the flow of blood through the blood lines (6, 7); an effluent fluid line (13) connected to an outlet of the secondary chamber (4); an ultrafiltration actuator connected to the effluent fluid line (13) and configured to cause a transfer of fluid from the primary (3) to the secondary chamber (4), and a control unit (10) configured to control the ultrafiltration actuator based on a set value (Qpfr set) for patient fluid removal rate, said set value (Qpfr set) being a desired value for the rate of fluid removal from the patient, wherein the control unit (10) is configured to execute at check points (Ti) during patient treatment a control procedure comprising:
      • receiving one check information selected in the group of:
        • a value of fluid removed from the patient (Vpfr removed; Vpfr(0)) over a time period (Ti-Tretro to Ti) preceding a check point (Ti),
        • an effective time portion, of said time period (Ti-Tretro to Ti) preceding a check point (Ti), during which said ultrafiltration actuator is operated,
        • a down time portion, of said time period (Ti-Tretro to Ti) preceding a check point (Ti), during which said ultrafiltration actuator is not operated,
      • calculating an updated value (Qpfr new) for said fluid removal rate (Qpfr) as a function of said set value for a fluid removal rate (Qpfr set) and of said check information.
  • In a 2nd aspect according to the 1st aspect, the control procedure further comprises, after calculation of said updated value (Qpfr new), controlling the ultrafiltration actuator after the check point as a function of said updated value (Qpfr new) for the fluid removal rate. In practice a new Qeff is calculated using (e.g. in formulas (1), (2) or (3)) Qpfr new in place of Qpfr set; and then used to control the ultrafiltration actuator, namely the waste pump positioned on the effluent line exiting from the second chamber.
  • In a 3rd aspect according to any one of 1stor 2nd aspect, the control procedure further comprises controlling the ultrafiltration actuator, after the check point and until either a subsequent check point as a function of said updated value (Qpfr new) for the fluid removal rate.
  • In a 4th aspect according to any one of 1stor 2 nd or 3 rd aspect the control unit (10) is configured for re-executing said control procedure at a plurality of check points (Ti) during patient treatment, said plurality of check points being one or more in the group of:
      • check points at regular intervals,
      • periodic check points,
      • check points triggered by specific setting of a new set value (Qpfr set) for patient fluid removal rate,
      • check points triggered by a stop in the ultrafiltration actuator,
      • check points triggered by each time a flow rate setting is changed.
  • In a 5th aspect according to any one of the preceding aspects, the control procedure comprises:
      • determining a value of the fluid removed from the patient (Vpfr removed) over a time period (Tretro) preceding a check point (Ti);
      • determining a value of fluid to be removed from the patient (Vpfr need)over a time period (Tprosp) following the check point (Ti) in order to achieve the set value (Qpfr set) for fluid removal rate (Qpfr) over the sum of the time period (Tretro) preceding check point (Ti) and of the time period (Tprosp) following the check point (Ti);
      • calculating the updated value (Qpfr new) for said fluid removal rate (Qpfr) based on said set value for a fluid removal rate (Qpfr set), on said value of fluid to be removed from the patient (Vpfr need)over the time period (Tprosp) following the check point (Ti) and on the duration the time period (Tprosp) following the check point (Ti).
  • In a 6th aspect according to any one of the preceding aspects, the control procedure comprises calculating the updated value (Qpfr new) for said fluid removal rate (Qpfr) at check point (Ti) according to the formula:

  • Q pfr new=[(T retro +T prospQ pfr set −V pfr removed ]/T prosp
  • where:
      • Qpfr set is the set value for fluid removal rate;
  • Vpfr removed is the value of the fluid removed from the patient over time period (Tretro) preceding a check point (Ti);
      • Tretro is a time period preceding check point (Ti);
      • Tprosp is a time period following the check point (Ti);
      • (Tretro+Tprosp) is the sum of the time period (Tretro) preceding check point (Ti) and of the time period (Tprosp) following the check point (Ti).
  • In a 7th aspect according to any one of the preceding aspects, each reference time interval (ΔT) is of prefixed duration, beginning at prefixed start times (T00; T00+ΔT; . . . ; T00+k·ΔT) and ending at prefixed ending times (T00+ΔT; T00+2ΔT; . . . ; T00+(k+1)·ΔT).
  • In a 8th aspect according to the 7th aspect the control procedure comprises calculating the updated value (Qpfr new) for said fluid removal rate (Qpfr) at check point (Ti) comprised between a start time (T00+k·ΔT) and an end time T00+(k+1)·ΔT according to the formula:

  • Q pfr new=(ΔT·Q pfr set −V pfr(0)) [(T 00+(k+1)·ΔT)−T i]
  • or

  • Q pfr new=(2·T·Q pfr set −V pfr(0) −V pfr(k−1))/[(T 00+(k+1)·ΔT)−T i]
  • where:
      • Qpfr set is the set value for fluid removal rate;
      • Vpfr(0) is the value of the fluid removed from the patient over time window running from (T00+k·ΔT) to check point (Ti);
      • Vpfr(k−1) is the value of the fluid removed from the patient over time window running from (T00+(k−1)·ΔT) to (T00+k·ΔT);
      • [(T00+(k+1)·ΔT)−Ti] is the duration of time period following the check point (Ti);
      • ΔT is the reference time interval.
  • In a 9th aspect according to any one of the preceding aspects, the control procedure comprises:
      • determining an effective portion (Teff) of said the time period (Tprosp; [T00+(k+1)·ΔT)−Ti]) following the check point (Ti), during which it is forecasted that the ultrafiltration actuator will be actually pulling fluid from the primary into the secondary chamber (4);
      • calculating the updated value (Qpfr new) for said fluid removal rate (Qpfr) using said effective portion (Teff) in place of the duration the time period following the check point (Ti).
  • In a 10th aspect according to any one of the preceding aspects the effective portion (Teff) is calculated reducing the duration of said the time period following check point (Ti) by a quantity linked to the number of bag changes expected in the next time period.
  • In a 11th aspect according to any one of the preceding aspects the effective portion (Teff) is calculated reducing the duration of said the time period following check point (Ti) by a quantity linked to down times caused by alarm conditions.
  • In a 12th aspect according to any one of the preceding aspects from the 5th to the 11th the effective portion (Teff) is calculated reducing the duration of said the time period following check point (Ti) by a quantity 11 linked to down times caused by alarm conditions if the duration of the time period (Tprosp) following the check point (Ti) is greater than a prefixed duration, such as grater than 30 mins or grater than 60 mins.
  • In a 13th aspect according to any one of the preceding aspects, the control unit is configured for receiving the set value (Qpfr set) for patient fluid removal rate from an operator's input or from a remote source communicatively connected to the control unit or for pre-storing said set value.
  • In a 14th aspect according to any one of the preceding aspects, the apparatus further comprises a user interface (12) connected to the control unit (10), said control unit being configured to execute the following before executing the control procedure:
      • display on the user interface an indicium prompting a user to select a set value (Qpfr set) for the patient fluid removal rate (Qpfr).
      • detect entry by the user of the set value (Qpfr set) for the patient fluid removal rate (Qpfr),
      • receive the entered set value (Qpfr set) for the patient fluid removal rate (Qpfr).
  • In a 15th aspect according to any one of the preceding aspects, the apparatus further comprises a pre-dilution fluid line (15) connected to the blood withdrawal line and a pre-dilution pump (18) connected to the control unit (10) and acting on the pre-dilution line for regulating the flow through said pre-dilution fluid.
  • In a 16th aspect according to any one of the preceding aspects, the apparatus further comprises a post-dilution fluid line (25) connected to the blood return line and a post-dilution pump (27) connected to the control unit (10) and acting on the post-dilution line for regulating the flow through said post-dilution fluid line.
  • In a 17th aspect according to any one of the preceding aspects, the apparatus further comprises a dialysis fluid line (19) connected to the inlet of the secondary chamber and a dialysis fluid pump (21) connected to the control unit (10) and acting on the dialysis liquid line for regulating the flow through said dialysis fluid line.
  • In a 18th aspect according to any one of the preceding aspects, the apparatus further comprises a pre-blood pump infusion line (22) connected to the blood withdrawal line in a region of this latter which is positioned in use upstream the blood pump, a pre-blood infusion pump (24) connected to the control unit (10) and acting on the pre-blood pump infusion line for regulating the flow through said pre-blood pump infusion line.
  • In a 19th aspect according to any one of the preceding aspects from the 15th to the 18th said control unit is configured to receive set values for one or more fluid flow rates selected in the group including a fluid flow rate (Qeff) through the effluent line (13), a fluid flow rate (Qrep, Qpbp) through the infusion fluid line (15, 22, 25), a fluid flow rate (Qdial) through the dialysis liquid fluid line (19), in addition to said fluid removal rate (Qpfr) from the patient and to control said pumps and said actuator based on the set values for said one or more fluid flow rates and for said fluid removal rate (Qpfr) from the patient.
  • In a 20th aspect according to any one of the preceding aspects from the 15th to the 18th, the apparatus further comprises a syringe pump connected to the blood withdrawal line and/or a syringe pump connected to the blood return line said control unit is configured to receive set values for the fluid flow rates through the syringe pump or syringe pumps and to control said infusion pumps, said dialysis pump and said ultrafiltration actuator based on the set values for said one or more fluid flow rates, for said fluid removal rate (Qpfr) from the patient, and on the set flow rates for the syringe pumps. In practice each line is controlled based on the respective set flow rate, except for the effluent line where the ultrafiltration actuator (e.g. a pump) is controlled based on the Qeff calculated using formulas (1), (2) or (3) described below in the detailed description, adopting Qpfr new in place of Qpfr set.
  • In a 21st aspect according to any one of the preceding aspects the control procedure comprises requesting the user, optionally via the user interface, to confirm that the calculated updated value (Qpfr new) for said fluid removal rate (Qpfr) is acceptable before using it for controlling the ultrafiltration actuator.
  • In a 22nd aspect according to any one of the preceding aspects the control procedure comprises comparing the calculated updated value (Qpfr new) for said fluid removal rate (Qpfr) against a maximum threshold value before using it for controlling the ultrafiltration actuator.
  • In a 23rd aspect according to any one of the preceding aspects the control procedure comprises executing one or more of the following safety checks:
      • comparing the ratio between the calculated updated value and the set value for the patient fluid removal rate with a first boundary condition (typically to ±30%),
      • comparing the absolute difference between the calculated updated value and the set value for the patient fluid removal rate with a second boundary condition (typically by ±100 ml/h),
      • comparing the absolute difference between the calculated updated value and the set value for the patient fluid removal rate as a function of patient body weight with a third boundary condition (typically by 0.1 ml/min/kg),
    • wherein the control procedure comprises verifying that a prefixed number, optionally all, of said checks is positively passed before using the update value for controlling the ultrafiltration actuator,
    • optionally wherein said control unit is configured for allowing setting of one or more of said boundary conditions.
  • In a 24th aspect according to any one of the preceding aspects the ultrafiltration actuator comprises a waste pump (17) acting on the effluent conduit (13), this latter leading to a waste container (14) configured for collecting fluid extracted from the secondary chamber (4);
    • at least one sensor (33) being associated to the waste container and being communicatively connected to the control unit, wherein the sensor is configured to:
      • determine the weight or the volume of the fluid in said waste container and
      • generate corresponding measurement signals (Wi) for the control unit, and wherein the control unit (10) is configured to calculate the actual quantity of fluid removed from the patient (Vpfr) over the reference time interval based at least on said measurement signals (Wi) coming from the sensor.
  • In a 25th aspect according to the preceding aspect, the apparatus comprises one or more of the following containers:
    • a pre-dilution fluid container connected to the pre-dilution line (15),
    • a post-dilution fluid container connected to the post-dilution fluid line (25),
    • a dialysis fluid container connected to the dialysis fluid line (19),
    • a pre-blood pump infusion fluid container connected to the pre-blood pump infusion (22) line,
    • a respective weighing sensor (34, 37, 35, 36) associated to each one of the above fluid containers and connected to the control unit (10),
    • wherein said control unit is configured to receive set values for one or more fluid flow rates selected in the group including a fluid flow rate (Qeff) through the effluent line (13), a fluid flow rate (Qrep, Qpbp) through the infusion fluid line (15, 21, 25), a fluid flow rate (Qdial) through the dialysis liquid fluid line (27), in addition to said fluid removal rate (Qpfr) from the patient, weigh signals (Wi) from said weighing sensors and to control said pumps and said actuator based on said weight signals, the set values for said one or more fluid flow rates and for said fluid removal rate (Qpfr) from the patient.
  • In a 26th aspect according to the preceding aspect, the apparatus comprises the following containers:
    • a pre-dilution fluid container connected to the pre-dilution line (15),
    • a post-dilution fluid container connected to the post-dilution fluid line (25),
    • a dialysis fluid container connected to the dialysis fluid line (19),
    • a respective weighing sensor associated to each one of the above fluid containers and connected to the control unit (10),
    • wherein said control unit is configured to receive set values for a fluid flow rate (Qeff) through the effluent line (13), a fluid flow rate (Qrep) through the infusion fluid line, a fluid flow rate (Qdial) through the dialysis liquid fluid line, in addition to said fluid removal rate (Qpfr) from the patient, weigh signals (Wi) from said weighing sensors and
    • to control said pumps and said actuator based on said weight signals, the set values for said fluid flow rates and for said fluid removal rate (Qpfr) from the patient.
  • A 27th aspect relates to a process for controlling an apparatus for extracorporeal treatment of blood, the apparatus being of the type comprising: a filtration unit (2) having a primary chamber (3) and a secondary chamber (4) separated by a semi-permeable membrane (5); a blood withdrawal line (6) connected to an inlet of the primary chamber (3), and a blood return line (7) connected to an outlet of the primary chamber (4) said blood lines being designed to be connected to a patient cardiovascular system; a blood pump (11) for controlling the flow of blood through the blood lines (6, 7); an effluent fluid line (13) connected to an outlet of the secondary chamber (4); an ultrafiltration actuator connected to the effluent fluid line (13) and configured to cause a transfer of fluid from the primary (3) to the secondary chamber (4). The process, which may for instance be executed by a control unit, includes the steps of:
      • controlling the ultrafiltration actuator based on a set value (Qpfr set) for patient fluid removal rate, said set value (Qpfr set) being a desired value for the rate of fluid removal from the patient,
      • executing at check points (Ti) during patient treatment a control procedure comprising:
        • receiving one check information selected in the group of:
          • a value of fluid removed from the patient (Vpfr removed; Vpfr(0)) over a time period (Ti-Tretro to Ti) preceding a check point (Ti),
          • an effective time portion, of said time period (Ti-Tretro to Ti) preceding a check point (Ti), during which said ultrafiltration actuator is operated,
          • a down time portion, of said time period (Ti-Tretro to Ti) preceding a check point (Ti), during which said ultrafiltration actuator is not operated,
      • calculating an updated value (Qpfr new) for said fluid removal rate (Qpfr) as a function of said set value for a fluid removal rate (Qpfr set) and of said check information.
  • In a 28th aspect according to the 27th aspect, the control procedure further comprises, after calculation of said updated value (Qpfr new), controlling the ultrafiltration actuator after the check point as a function of said updated value (Qpfr new) for the fluid removal rate. In practice a new Qeff is calculated using (e.g. in formulas (1), (2) or (3)) Qpfr new in place of Qpfr set; and then used to control the ultrafiltration actuator, namely the waste pump positioned on the effluent line exiting from the second chamber.
  • In a 29th aspect according to any one of the preceding 2 aspects, the control procedure further comprises controlling the ultrafiltration actuator, after the check point and until either a subsequent check point as a function of said updated value (Qpfr new) for the fluid removal rate.
  • In a 30th aspect according to any one of the preceding 3 aspects comprising re-executing said control procedure at a plurality of check points (Ti) during patient treatment, said plurality of check points being one or more in the group of:
      • check points at regular intervals,
      • periodic check points,
      • check points triggered by specific setting of a new set value (Qpfr set) for patient fluid removal rate,
      • check points triggered by a stop in the ultrafiltration actuator,
      • check points triggered by each time a flow rate setting is changed.
  • In a 31st aspect according to any one of the preceding 4 aspects, the control procedure comprises:
      • determining a value of the fluid removed from the patient (Vpfr removed) over a time period (Tretro) preceding a check point (Ti);
      • determining a value of fluid to be removed from the patient (Vpfr need) over a time period (Tprosp) following the check point (Ti) in order to achieve the set value (Qpfr set) for fluid removal rate (Qpfr) over the sum of the time period (Tretro) preceding check point (Ti) and of the time period (Tprosp) following the check point (Ti);
      • calculating the updated value (Qpfr new) for said fluid removal rate (Qpfr) based on said set value for a fluid removal rate (Qpfr set), on said value of fluid to be removed from the patient (Vpfr need) over the time period (Tprosp) following the check point (Ti) and on the duration the time period (Tprosp) following the check point (Ti).
  • In a 32nd aspect according to any one of the preceding 5 aspects, the control procedure comprises calculating the updated value (Qpfr new) for said fluid removal rate (Qpfr) at check point (Ti) according to the formula:

  • Q pfr new=[(T retro +T prospQ pfr set −V pfr removed ]/T prosp
  • where:
      • Qpfr set is the set value for fluid removal rate;
      • Vpfr removed is the value of the fluid removed from the patient over time period (Tretro) preceding a check point (Ti);
      • Tretro is a time period preceding check point (Ti);
      • Tprosp is a time period following the check point (Ti);
      • (Tretro+Tprosp) is the sum of the time period (Tretro) preceding check point (Ti) and of the time period (Tprosp) following the check point (Ti).
  • In a 33rd aspect according to any one of the preceding 6 aspects, each reference time interval (ΔT) is of prefixed duration, beginning at prefixed start times (T00; T00+ΔT; . . . ; T00+k·ΔT) and ending at prefixed ending times (T00+ΔT; T00+2ΔT; . . . ; T00+(k+1)·ΔT).
  • In a 34th aspect according to the preceding aspect the control procedure comprises calculating the updated value (Qpfr new) for said fluid removal rate (Qpfr) at check point (Ti) comprised between a start time (T00+k·ΔT) and an end time T00+(k+1)·ΔT according to the formula:

  • Qpfr new=(ΔT·Q pfr set −V pfr(0))/[(T 00+(k+1)·ΔT)−T i]
  • or
  • Q pfr new=(2·ΔT·Q pfr set −V pfr(0) −V pfr(k−1))/[(T 00+(k+1)·ΔT)−T i]
  • where:
      • Qpfr set is the set value for fluid removal rate;
      • Vpfr(0) is the value of the fluid removed from the patient over time window running from (T00+k·ΔT) to check point (Ti);
      • Vpfr(k−1) is the value of the fluid removed from the patient over time window running from (T00+(k−1)·ΔT) to (T00+k·ΔT);
      • [(T00+(k+1)·ΔT)−Ti] is the duration of time period following the check point (Ti);
      • ΔT is the reference time interval.
  • In a 35th aspect according to any one of the preceding 8 aspects, the control procedure comprises:
      • determining an effective portion (Teff) of said the time period (Tprosp; [T00+(k+1)·ΔT)−Ti]) following the check point (Ti), during which it is forecasted that the ultrafiltration actuator will be actually pulling fluid from the primary into the secondary chamber (4);
      • calculating the updated value (Qpfr new) for said fluid removal rate (Qpfr) using said effective portion (Teff) in place of the duration the time period following the check point (Ti).
  • In a 36th aspect according to any one of the preceding 9 aspects the effective portion (Teff) is calculated reducing the duration of said the time period following check point (Ti) by a quantity linked to the number of bag changes expected in the next time period.
  • In a 37th aspect according to any one of the preceding 10 aspects the effective portion (Teff) is calculated reducing the duration of said the time period following check point (Ti) by a quantity linked to down times caused by alarm conditions.
  • In a 38th aspect according to any one of the preceding 7 aspects the effective portion (Teff) is calculated reducing the duration of said the time period following check point (Ti) by a quantity 11 linked to down times caused by alarm conditions if the duration of the time period (Tprosp) following the check point (Ti) is greater than a prefixed duration, such as grater than 30 mins or grater than 60 mins.
  • In a 39th aspect according to any one of the preceding aspects, the process includes receiving the set value (Qpfr set) for patient fluid removal rate from an operator's input or from a remote source communicatively connected to the control unit or for pre-storing said set value.
  • In a 40th aspect according to any one of the preceding 13 aspects, the process comprises executing the following steps before executing the control procedure:
      • display on a user interface an indicium prompting a user to select a set value (Qpfr set) for the patient fluid removal rate (Qpfr),
      • detect entry by the user of the set value (Qpfr set) for the patient fluid removal rate (Qpfr),
      • receive the entered set value (Qpfr set) for the patient fluid removal rate (Qpfr).
  • In a 41th aspect according to any one of the preceding 14 aspects, the apparatus is of the type disclosed in any one of aspects from the 15th to the 20th.
  • In a 42nd aspect according to any one of the preceding 15 aspects the control procedure comprises comparing the calculated updated value (Qpfr new) for said fluid removal rate (Qpfr) against a maximum threshold value before using it for controlling the ultrafiltration actuator.
  • In a 43rd aspect according to any one of the preceding 16 aspects the control procedure comprises executing one or more of the following safety checks:
      • comparing the ratio between the calculated updated value and the set value for the patient fluid removal rate with a first boundary condition (typically to ±30%),
      • comparing the absolute difference between the calculated updated value and the set value for the patient fluid removal rate with a second boundary condition (typically by ±100 ml/h),
      • comparing the absolute difference between the calculated updated value and the set value for the patient fluid removal rate as a function of patient body weight with a third boundary condition (typically by 0.1 ml/min/kg),
        wherein the control procedure comprises verifying that a prefixed number, optionally all, of said checks is positively passed before using the update value for controlling the ultrafiltration actuator.
  • In a 44th aspect according to any one of the preceding aspects the ultrafiltration actuator comprises a waste pump (17) acting on the effluent conduit (13), this latter leading to a waste container (14) configured for collecting fluid extracted from the secondary chamber (4);
    • at least one sensor (33) being associated to the waste container and being communicatively connected to the control unit, wherein the sensor is configured to:
      • determine the weight or the volume of the fluid in said waste container and
      • generate corresponding measurement signals (Wi) for the control unit, and wherein the process comprises the step of calculating the actual quantity of fluid removed from the patient (Vpfr) over the reference time interval based at least on said measurement signals (Wi) coming from the sensor.
  • In a 45th aspect according to the preceding aspect, the apparatus comprises one or more of the following containers:
    • a pre-dilution fluid container connected to the pre-dilution line (15),
    • a post-dilution fluid container connected to the post-dilution fluid line (25),
    • a dialysis fluid container connected to the dialysis fluid line (19),
    • a pre-blood pump infusion fluid container connected to the pre-blood pump infusion (22) line,
    • a respective weighing sensor (34, 37, 35, 36) associated to each one of the above fluid containers and connected to the control unit (10),
    • wherein said process comprises receiving set values for one or more fluid flow rates selected in the group including a fluid flow rate (Qeff) through the effluent line (13), a fluid flow rate (Qrep, Qpbp) through the infusion fluid line (15, 21, 25), a fluid flow rate (Qdial) through the dialysis liquid fluid line (27), in addition to said fluid removal rate (Qpfr) from the patient, weigh signals (Wi) from said weighing sensors and to control said pumps and said actuator based on said weight signals, the set values for said one or more fluid flow rates and for said fluid removal rate (Qpfr) from the patient.
  • In a 46th aspect a data carrier including instructions executable by a control unit of a blood treatment (for instance of the blood treatment device of any one of aspects from 1st to 26th apparatus) is provided. The instructions are configured such that, when executed by the control unit, they cause execution of the process according to any one of the preceding aspects from 27th to 45th.
  • In a 47TH aspect according to the preceding aspect the data carrier may be any support suitable for storing data, such as by way of non-limiting example: a RAM, a ROM, an EPROM, an optical or a magnetic disc, an electromagnetic wave, a mass memory storage device such as an Hard Disk or a flash memory bank.
  • DESCRIPTION OF THE DRAWINGS
  • Aspects of the invention are shown in the attached drawings, which are provided by way of non-limiting example, wherein:
  • FIG. 1 shows a schematic diagram of a blood treatment apparatus according to one aspect of the invention,
  • FIG. 2 shows a schematic diagram of an alternative embodiment of a blood treatment apparatus according to another aspect of the invention,
  • FIG. 3 shows a schematic diagram of a further alternative embodiment of a blood treatment apparatus according to another aspect of the invention,
  • FIG. 4 shows a block diagram of a procedure executable by a control unit according to a further aspect of the invention,
  • FIG. 5 graphically shows a first example of a control procedure according to aspects of the invention,
  • FIG. 6 graphically shows a second example of a control procedure according to aspects of the invention, and
  • FIG. 7 graphically shows a third example of a control procedure according to aspects of the invention.
  • DETAILED DESCRIPTION
  • FIGS. 1, 2 and 3 show exemplifying, and non limiting, embodiments of an apparatus for extracorporeal treatment of blood. Note that same components are identified by same reference numerals in FIGS. 1-3.
  • FIG. 1 shows an apparatus 1 designed for delivering any one of treatments like hemodialysis, hemofiltration, hemodiafiltration, and ultrafiltration.
  • In fact, the apparatus 1 comprises a filtration unit 2 having a primary chamber 3 and a secondary chamber 4 separated by a semi-permeable membrane 5; depending upon the treatment, the membrane of the filtration unit may be selected to have different properties and performances. A blood withdrawal line 6 is connected to an inlet of the primary chamber 3, and a blood return line 7 is connected to an outlet of the primary chamber 3. In use, the blood withdrawal line 6 and the blood return line 7 are connected to a needle or to a catheter or other access device (not shown) which is then placed in fluid communication with the patient vascular system, such that blood can be withdrawn through the blood withdrawal line, flown through the primary chamber and then returned to the patient's vascular system through the blood return line. An air separator, such as a bubble trap 8 may be present on the blood return line; moreover, a safety clamp 9 controlled by a control unit 10 may be present on the blood return line downstream the bubble trap 8. A bubble sensor 8 a, for instance associated to the bubble trap 8 or coupled to a portion of the line 7 between bubble trap 8 and clamp 9 may be present: if present, the bubble sensor is connected to the control unit 10 and sends to the control unit signals for the control unit to cause closure of the clamp 9 in case one or more bubbles above certain safety thresholds are detected. As shown in FIG. 1, the blood flow through the blood lines is controlled by a blood pump 11, for instance a peristaltic blood pump, acting either on the blood withdrawal line (as shown in FIG. 1) or on the blood return line. An operator may enter a set value for the blood flow rate QB through a user interface 12 and the control unit 10, during treatment, is configured to control the blood pump based on the set blood flow rate. The control unit may comprise a digital processor (CPU) and memory (or memories), an analogical type circuit, or a combination thereof as explained in greater detail in below section dedicated to the ‘control unit’. An effluent fluid line 13 is connected, at one end, to an outlet of the secondary chamber 4 and, at another end, to an effluent fluid container 14 collecting the fluid extracted from the secondary chamber. The embodiment of FIG. 1 also presents a pre-dilution fluid line 15 connected to the blood withdrawal line: this line 15 supplies replacement fluid from an infusion fluid container 16 connected at one end of the pre-dilution fluid line. Note that alternatively to the pre-dilution fluid line the apparatus of FIG. 1 may include a post-dilution fluid line (not shown in FIG. 1) connecting an infusion fluid container to the blood return line. Finally, as a further alternative (not shown in FIG. 1) the apparatus of FIG. 1 may include both a pre-dilution and a post infusion fluid line: in this case each infusion fluid line may be connected to a respective infusion fluid container or the two infusion fluid lines may receive infusion fluid from a same source of infusion fluid such as a same infusion fluid container. An effluent fluid pump 17 operates on the effluent fluid line under the control of said control unit 10 to regulate the flow rate Qeff across the effluent fluid line. Furthermore, an infusion pump 18 operates on the infusion line 15 to regulate the flow rate Qrep through the infusion line. Note that in case of two infusion lines (pre-dilution and post-dilution) each infusion line may cooperate with a respective infusion pump. The apparatus of FIG. 1, further includes a dialysis fluid line 19 connected at one end with a dialysis fluid container 20 and at its other end with the inlet of the secondary chamber 4 of the filtration unit. A dialysis liquid pump 21 works on the dialysis liquid fluid line under the control of said control unit 10, to supply fluid from the dialysis liquid container to the secondary chamber at a flow rate Qdial.
  • The dialysis fluid pump 21, the infusion fluid pump 15 and the effluent fluid pump 17 are operatively connected to the control unit 10 which controls the pumps as it will be in detail disclosed herein below. The control unit 10 is also connected to the user interface 12, for instance a graphic user interface, which receives operator's inputs and displays the apparatus outputs. For instance, the graphic user interface 12 may include a touch screen, a display screen and hard keys for entering user's inputs or a combination thereof.
  • The embodiment of FIG. 2 shows an alternative apparatus 1 where the same components described for the embodiment of FIG. 1 are also presents and are identified by same reference numerals and thus not described again. Additionally, the apparatus 1 shown in FIG. 2 may present a further infusion line 22 connected, at one end, with a portion 6 a of the blood withdrawal line 6 positioned upstream the blood pump 11 and, at its other end, with a further infusion fluid container 23, which for instance may contain a drug, or a regional anticoagulant such as a citrate solution, or a nutrients solution or other. This further infusion line is herein referred to as pre-blood pump infusion line 22. A pump 24, for instance a peristaltic pump controlled by control unit 10, may act on a segment of the pre-blood pump infusion line to regulate a pre-blood pump infusion rate Qpbp.
  • The apparatus of FIG. 2, may also present a post-dilution line 25 (represented with dashed line) connected at one end with a further container 26 of infusion liquid and connected at its other end with the blood return line 7. A further pump 27, for instance a peristaltic pump, may act under the control of control unit 10 on the post-dilution line 25.
  • A third embodiment is shown in FIG. 3. The apparatus of FIG. 3 is an ultrafiltration apparatus comprising a filtration unit 2 (in this case an ultrafilter) having a primary chamber 3 and a secondary chamber 4 separated by a semi-permeable membrane 5. A blood withdrawal line 6 is connected to an inlet of the primary chamber 3, and a blood return line 7 is connected to an outlet of the primary chamber 3. As in the embodiment of FIG. 1, the blood withdrawal line 6 and the blood return line 7 are connected in use to a needle or to a catheter or other access device (not shown) which is then placed in fluid communication with the patient vascular system, such that blood can be withdrawn through the blood withdrawal line, flown through the primary chamber and then returned to the patient's vascular system through the blood return line. An air separator, such as a bubble trap 8 may be present on the blood return line; moreover, a safety clamp 9 controlled by a control unit 10 may be present on the blood return line downstream the bubble trap 8. A bubble sensor 8 a, for instance associated to the bubble trap 8 or coupled to a portion of the line 7 between bubble trap 8 and clamp 9 may be present: if present, the bubble sensor is connected to the control unit 10 and sends to the control unit signals for the control unit to cause closure of the clamp 9 in case one or more bubbles above certain safety thresholds are detected. As shown in FIG. 1, the blood flow through the blood lines is controlled by a blood pump 11, for instance a peristaltic blood pump, acting either on the blood withdrawal line (as shown in FIG. 1) or on the blood return line. An operator may enter a set value for the blood flow rate QB through a user interface 12 and the control unit 10, during treatment, is configured to control the blood pump based on the set blood flow rate. The control unit may comprise a digital processor (CPU) and memory (or memories), an analogical type circuit, or a combination thereof as explained in greater detail in below section dedicated to the ‘control unit’. An effluent fluid line 13 is connected, at one end, to an outlet of the secondary chamber 4 and, at another end, to an effluent fluid container 14 collecting the fluid extracted from the secondary chamber. An effluent fluid pump 17 operates on the effluent fluid line under the control of said control unit 10 to regulate the flow rate Qeff across the effluent fluid line. The control unit 10 is also connected to the user interface 12, for instance a graphic user interface, which receives operator's inputs and displays the apparatus outputs. For instance, the graphic user interface 12 may include a touch screen, a display screen and hard keys for entering user's inputs or a combination thereof.
  • In each one of the above described embodiments an ultrafiltration actuator, comprising the effluent fluid pump 17, is inserted into the effluent fluid line 13 and configured to cause a transfer of fluid from the primary 3 to the secondary chamber 4; in practice, in the embodiment of FIG. 1 the control unit may drive the dialysis liquid pump 21, the infusion pump 18 and the effluent pump 17 such that Qeff is equal to Qdial+Qrep1+Qpfr; in other words, the control unit drives the mentioned pumps so that the total flow rate flowing through the effluent line is made equal to the sum of the flow rate through the fresh dialysis liquid line, the flow rate through the replacement fluid line and the patient fluid removal rate which is to be imposed on the patient. In the embodiment of FIG. 2 the control unit may drive the dialysis liquid pump 21, the infusion pumps 18 and 27, the pre-blood pump infusion pump 24 and the effluent pump 17 such that Qeff is made equal to Qdial+Qrep1+Qrep2+Qpbp+Qpfr; in the embodiment of FIG. 3, the flow Qeff equals Qpfr as there is no dialysate or infusion line. Although this is not shown in the enclosed figures, note that the extracorporeal blood treatment apparatus 1 (e.g. the apparatus 1 of FIGS. 1 or 2 or 3) may include one or more syringe pumps: for instance a syringe pump connected to the blood withdrawal line 6 and a syringe pump connected to the blood return line 7; of course only one syringe may be used either connected to line 6 or to line 7. In this case, Qeff would be controlled to account for the flow rate delivered by said syringe pump(s). In FIGS. 1, 2, 3, Quf represents the ultrafiltration flow rate, namely the flow rate passing through the semi-permeable membrane 5 (Qpfr=Quf in the case where there is pure ultrafiltration or pure hemodialysis, while Quf=Qpfr+Qrep1 and/or +Qrep2 in case there are one or more infusions through respective fluid replacement lines).
  • In order to measure the quantity of fluid delivered or collected in each container, appropriate sensors are used. For instance, referring to FIGS. 1 and 2, the apparatus 1 also comprises a first scale 33 operative for providing weight information W1 relative to the amount of the fluid collected in the effluent fluid container 14; a second scale 34 operative for providing weight information W2 relative to the amount of the fluid supplied from the infusion fluid container 16; a third scale 35 operative for providing weight information W3 relative to the amount of the fluid supplied from dialysis fluid container 20. In case more infusion lines would be present, as infusion lines 22 and 25 in FIG. 2, then a respective fourth and fifth scales 36 and 37 could be present to provide weight information W4, W5 relative to the amount of fluid supplied from infusion container 23 and from infusion container 26. In the apparatus of FIG. 3, a single scale 33 is present which is operative for providing weight information relative to the amount of the fluid collected in the effluent fluid container 14. The scales are all connected to the control unit 10 and provide said weight information Wi for the control unit to determine the actual quantity of fluid in each container as well as the actual flow rate of fluid supplied by or received in each container. The control unit may also be configured to receive weight information Wi from the first scale and, depending upon the selected treatment and type of apparatus, from one or more of the other the scales and to control the flow rate through the effluent fluid line, the infusion fluid line (if present), the dialysis fluid line (if present) by controlling the respective pumps based on said weight information Wi, and on initial set values.
  • From a structural point of view one or more, all containers 14, 16, 20, 23 may be disposable plastic containers, for instance bags which are hang on a support carried by the respective scale. All lines and the filtration unit may also be plastic disposable components which may be mounted at the beginning of the treatment session and then disposed of at the end of the treatment session. Pumps, e.g. peristaltic pumps, have been described as means for regulating fluid flow through each of the lines; however it should be noted that other flow regulating means could alternatively be adopted such as for example valves or combinations of valves and pumps. The scales may comprise piezoelectric sensors, or strain gauges, or spring sensors, or any other type of transducer able to sense forces applied thereon. Although the examples in the figures show use of scales for determining the amount of fluid in the respective containers and for allowing calculation of the respective flow rates through the various lines, it should be noted that volumetric sensors for determining flow rates or combinations of mass and volumetric sensors may alternatively be adopted.
  • Operation
  • Reference is made by way of non limiting example to the flowchart of FIG. 4. The control unit 10 is configured to control the ultrafiltration actuator (e.g. by controlling at least the effluent pump 17) based on a set value Qpfr set and to control the other pumps (such as pumps 18, 21, 24, 27 and the syringe(s)) if present) based on set values initially set by an operator or pre-stored in the machine or received from a source external to the machine; for instance, with reference to FIG. 4, the control unit 10 may receive (step 100) set values for one or more of the flow rates Qrep set to be imposed through the infusion lines (when present), the set value Qdial set to be imposed through the dialysis liquid line (when present) and the set value Qpfr set for the patient fluid removal rate which is a desired value for the rate of fluid removal from the patient which is to be maintained during treatment. In the case of the apparatus of FIG. 3, the control unit 10 would be only receive the set value for the patient fluid removal rate Qpfr set and would be configured to control the ultrafiltration actuator based on said set value Qpfr set. Then, the control unit may calculate the value Qeff set (step 101):

  • Q eff set =Q dial set +Q rep set +Q pfr set   (1)
  • Note that in case there is a pre-blood pump infusion line either the user shall enter a set value Qpbp set for the flow rate Qpbp of the respective pump 22, or the control unit is configured to calculate the set value Qpbp set as a function of the set blood flow rate QB set. In any case, if a pre-blood pump infusion line is present, the set flow rate is considered in equation (1) above and added at second member as follows:

  • Q eff set =Q dial set +Q rep set +Q pbp set +Q pfr set   (2).
  • Of course, in case there is no infusion line and no dialysis line then equation (2) becomes:

  • Qeff set=Qpfr set   (3).
  • Then, the control unit uses the calculated Qeff set as value of the effluent flow rate Qeff (step 101 a) which is used to control the flow of fluid through the effluent line. In detail, the control unit may control (step 102) each of the infusion pumps and the dialysis pump such that the actual flow rate matches the respective set flow rate and may control the effluent pump 17 (or ultrafiltration actuator) such that the actual flow rate through the effluent line matches the calculated value Qeff set. In other words, once the Qeff set has been calculated as a function of Qpfr set, then Qeff set may be used as Qeff to control the ultrafiltration actuator, e.g. the effluent pump 17 in the examples of FIGS. 1-3.
  • The control unit 10 is also configured to execute at check points Ti (step 103) during patient treatment a control procedure comprising the steps 104, 105 and 106 as schematically shown in the flow chart of FIG. 4.
  • The control unit 10 may be configured for re-executing the control procedure at a plurality of check points Ti during patient treatment: various criteria may be adopted to identify the check points Ti. For instance the control procedure may be repeated at periodic check points or at check points separated by time intervals following a prescribed rule (i.e. the time intervals between consecutive check points may not be all equal but nevertheless follow a prescribed rule). According to a further alternative the control procedure may be activated at check points triggered by specific events, such as a downtime of the machine due to a bag change or other reason, setting of a new set value Qpfr set for patient fluid removal rate, or setting of a new set value for any one of the flow rates Qrep set, Qpbp set through the infusion lines (when present), the set value Qdial set to be imposed through the dialysis liquid line (when present).
  • Going now into the details of the exemplifying embodiment of FIG. 4, the control procedure comprises the following steps.
  • Step 104: receiving one check information selected in the group of:
      • a. a value of fluid removed from the patient over a time period preceding a check point
  • Ti; this value may be calculated or measured by the scale or scales.
      • b. an effective time portion, of said time period preceding a check point, during which said ultrafiltration actuator is operated; this value may be measured by the apparatus taking detecting all intervals when the machine or the treatment is stopped, e.g. due to an alarm or due to a bag change or due to a change of the disposable set or due to other reasons.
      • c. a down time portion, of said time period preceding a check point Ti, during which said ultrafiltration actuator is not operated; this value may be measured by the apparatus taking detecting all intervals when the machine or the treatment is stopped, e.g. due to an alarm or due to a bag change or due to a change of the disposable set or due to other reasons.
  • Step 105: calculating an updated value Qpfr new for said fluid removal rate Qpfr as a function of said set value for a fluid removal rate Qpfr set and of said check information. In most cases where the machine or the treatment has been interrupted in the period preceding a, the new value Qpfr new is higher than the set value Qpfr set. Note, however, that there may be cases (e.g. if there is a flow delivery problem on dialysate or replacement) where too much fluid could have been extracted in the period preceding a check point: in such a situation the new value Qpfr new is smaller than the set value Qpfr set.
  • Steps 106: after calculation of said updated value Qpfr new, the control unit is configured for calculating a new Qeff for then returning to step 102.
  • At step 102 the control unit controls the ultrafiltration actuator (and the other pumps if present as above described in connection with step 102) as a function of said new Qeff and therefore as a function of the updated value Qpfr new of the fluid removal rate. The control may use one of algorithms (1) or (2) or (3) depending upon the apparatus configuration, adopting Qpfr new in place of Qpfr set
  • The control with the updated value may start immediately after the check point and last until a subsequent check point.
  • Here below some implementing examples are provided in order to exemplify the operation of apparatuses according to the invention. In below examples it is assumed that the set patient fluid flow rate Qpfr set is not changed in the time period preceding a check point.
  • EXAMPLE 1
  • FIG. 5 shows a first example of implementation of the control procedure which has been described herein above.
  • In this embodiment, the control procedure comprises:
      • determining a value of the fluid removed from the patient Vpfr removed over a time period Tretro preceding a check point Ti;
      • determining a value of fluid to be removed from the patient Vpfr need over a time period Tprosp following the check point Ti in order to achieve the set value Qpfr set for fluid removal rate Qpfr over the sum of the time period Tretro preceding check point Ti and of the time period Tprosp following the check point (Ti); in FIG. 5, Tretro is equal to Tprosp: although this may be a preferred option, it should be noted that Tretro may also be different from Tprosp.
      • calculating the updated value Qpfr new for said fluid removal rate Qpfr based on the set value for a fluid removal rate Qpfr set, on the value of fluid to be removed from the patient Vpfr need over the time period Tprosp following the check point (Ti) and on the duration the time period Tprosp following the check point Ti.
  • For example the following formula may be adopted for the calculation of Qpfr new:

  • Q pfr new=[(T retro +T prospQ pfr set −V pfr removed)/T prosp   (4)
  • where:
      • Qpfr set is the set value for fluid removal rate;
      • Vpfr removed is the value of the fluid removed from the patient over time period Tretro preceding a check point Ti;
      • Tretro is a time period preceding check point Ti;
      • Tprosp is a time period following the check point Ti;
      • (Tretro+Tprosp) is the reference time interval which is the sum of the time period Tretro preceding check point Ti and of the time period Tprosp following the check point Ti.
  • The ‘check point’ Ti, when instantaneous Qpfr new is computed may be done:
      • after each treatment interruption (down time),
      • on a periodic basis,
      • each time the a flow rate setting is changed,
      • by time Ti+Tprosp.
  • In the context of patient fluid removal management, relevant values for Tretro and Tprosp may be in the range of 1 to 6-8 hours.
  • Applying the above algorithm to the apparatus of FIG. 3 assuming that:
      • the operator initially sets a Qpfr set=100 ml/h,
      • Tretro and Tprosp both equal to 4 h,
      • the fluid actually removed Vpfr removed from the patient as measured by scale 33 (in case the apparatuses of FIGS. 1 and 2 would be used then information from all scales would be received by the control unit) over time period Tretro=4 h preceding check point T1 is Vpfr removed=390 ml,
        then applying formula (4) above:

  • Q pfr new=(ΔT·Q pfr set −V pfr removed)/T prosp=[(4+4)·100−390]/4=102.5 ml/h
  • Thus, the control unit 10 will control the pump 17 based on the new calculated value of 102.5 ml/h during the 4 h following the first check point.
  • EXAMPLE 2
  • FIG. 6 shows a second example of implementation of the control procedure which has been described herein above.
  • In this case, the procedure aims at achieving the most accurate Patient Fluid Removal over predefined time periods. In this example, periods of constant duration ΔT are prefixed, beginning at a prefixed time T00:

  • T00; T00+ΔT; . . . ; T00+k·ΔT
  • and ending at prefixed ending times

  • T00+ΔT; T00+2ΔT; . . . ; T00+(k+1)·ΔT.
  • In this variant, the control unit 10 aims at delivering the exact patient fluid removal prescription over predefined time windows, such as matching with staff shifts or simply ‘round hours’ (13:00, 14:00, 15:00 . . . ).
  • The ‘check point’ Ti when instantaneous Qpfr new is computed may be done:
      • at each treatment interruption (down time),
      • at each time a flow rate setting is changed,
      • at each predefined time window limit (T00+k.T),
  • According to this variant, the control procedure comprises calculating the updated value Qpfr new for said fluid removal rate Qpfr at check point Ti comprised between a start time T00+k·ΔT and an end time T00+(k+1)·ΔT according to the formula:

  • Q pfr new=(ΔT·Q pfr set −V pfr(0))/[(T 00+(k+1)·T)−T i]  (5)
  • or according to the formula (which takes into account the volume of fluid removed in a further time window):

  • Q pfr new=(2·ΔT·Q pfr set −V pfr(0) −V pfr(k−1))/[(T 00+(k+1)·ΔT)−T i]  (6)
  • where:
    • Qpfr set is the set value for fluid removal rate;
    • Vpfr(0) is the value of fluid removed from patient over time window running from (T00+k·ΔT) to check point (Ti);
    • Vpfr(k−1 ) is the value of fluid removed from patient over time window running from (T00+(k−1)·ΔT) to (T00+k·ΔT);
    • [(T00+(k+1)·ΔT)−Ti] is the duration of time period following the check point (Ti);
    • ΔT is the duration of the reference time interval.
  • Note:
  • Formula 5 is equivalent to formula 4 with:

  • T retro +T prosp =ΔT

  • T prosp=(T 00+(k+1)·ΔT)−Ti
  • Formula 6 is equivalent to formula 4 with:

  • T retro +T prosp=2ΔT

  • T prosp=(T 00+(k+1)·ΔT)−T,
  • Applying the above algorithm to the apparatus of FIG. 3 assuming that:
      • the operator initially sets a Qpfr set=100 ml/h;
      • Predefined time windows: 0:00; 4:00; 8:00; 12:00; 16:00; 20:00;
      • Check time Ti: 10:30,
      • the fluid actually removed over [4:00; 8:00] as measured by scale 33 (of course in case the apparatuses of FIGS. 1 and 2 would be used then information from all scales would be received by the control unit) is Vpfr(k−1)=396 ml;
      • the fluid actually removed over [4:00; 10:30] as measured by scale 33 (of course in case the apparatuses of FIGS. 1 and 2 would be used then information from all scales would be received by the control unit) is Vpfr(0)=245 ml,
        then applying formula (6) above:

  • Q pfr new=(2·4·100−245−396)/(12−10.5)=106.0 ml/h
  • Thus, the control unit 10 will control the pump 17 based on the new calculated value of 106.0 ml/h during the 1.5 h following the check point at 10.30 in order to achieve the desired patient fluid removal by 12.00.
  • Anticipation of Down Times
  • Performance of the previous algorithms may be further enhanced when anticipating ‘future’ down times.
  • Several types of down-times may be estimated:
      • related to bag management: flow rate and bag volume data available to the system allow anticipating the number of bag changes which will occur over the period of interest; corresponding down time of the ultrafiltration actuator may then be derived using an assumption of the time used for changing a bag; such an estimate may derive from general statistical data or statistics more specific to the system in use and the local handling processes;
      • related to alarms: a simple alarm down time coefficient may be applied to estimate for the down times related to alarms interrupting the ultrafiltration actuator. Again such a coefficient may be built in the system or derived from statistics specific on the system in use.
  • By calculating the impact of the above down times it is possible to account for the effective portion Teff of the time period after check time Ti during which it is forecasted that the ultrafiltration actuator will be actually pulling fluid from the primary into the secondary chamber 4. This allows further correcting the value of the new calculated patient fluid removal rate.
  • In practice, the control procedure described above may comprises a step of determining an effective portion Teff of said the time period Tprosp or (T00+(k+1)·ΔT)−Ti following the check point Ti. Then, the updated value Qpfr new for the fluid removal rate Qpfr is calculated by the control unit using Teff in place of the duration the time period following the check point Ti, i.e. in place of Tprosp or (T00+(k+1)·ΔT)−Ti.
  • EXAMPLE 3
  • The following example is similar to Example 2 (reference is made to FIGS. 3 and 6) and shows calculation and use of the effective portion Teff which is determined in this case by reducing the duration of the time period following check point Ti by a first quantity linked to a bag change average time expected to be spent in the next time period and by a second quantity linked to down times caused by alarm conditions.
  • Applying algorithm (6) to the apparatus of FIG. 3 assuming that:
      • the operator initially sets a Qpfr set=100 ml/h;
      • Predefined time windows: 0:00; 4:00; 8:00; 12:00; 16:00; 20:00;
      • Check time Ti: 10:30,
      • the fluid actually removed over [4:00; 8:00] as measured by scale 33 is Vpfr(k−1)=396 ml;
      • the fluid actually removed over [4:00; 10:30] as measured by scale 33 is Vpfr(0)=245 ml;
      • Number of bag changes planned over [10:30; 12:00]: Nchange bag=2;
      • Mean time for changing a bag: Tchange bag=100 s;
      • Alarm down time coefficient: Kalarm=1.7%,
  • Thus, the effective run time of ‘prospective’ time window [10:30; 12:00] is:

  • T eff=1.5−0.017·1.5−2·(100/3600)=1.42 h
  • It should be noted that in calculating Teff, where Tprosp becomes small (e.g. <30 minutes) the predictive term due to alarms may be ignored.
  • Then applying formula (6) using the calculated Teff:

  • Q pfr new=(2·4·100−245−396)/(1.42)=112.1 ml/h
  • Thus, the control unit 10 will control the pump 17 based on the new calculated value of 112.1 ml/h during the 1.5 h following the check point at 10.30 in order achieve the most accurate delivery of the desired patient fluid removal over the time periods [4:00; 8:00] and [8:00; 12:00]. According to the criteria used for deciding on check points, this flow rate will be further adjusted at least twice before the current time period [8:00; 12:00] is elapsed (2 planned bag changes).
  • EXAMPLE 4
  • FIG. 7 shows another example of implementation of the control procedure which has been described herein above.
  • In this case, and as in example 2, the procedure aims at achieving the most accurate Patient Fluid Removal over predefined time periods. However, in this example, the time periods are defined around the clock and may be of different durations.
  • N clock times between 0:00 and 24:00 (T1, T2, . . . Tk, . . . TN) define N time periods [Tk, Tk+1] (for k=1 to N and TN+1=T1).
  • In this variant, the control unit 10 aims at delivering the exact patient fluid removal prescription over each predefined time window, such as matching with staff shifts.
  • The ‘check point’ Ti when instantaneous Qpfr new is computed may be done:
      • at each treatment interruption (down time),
      • at each time a flow rate setting is changed,
      • at each predefined clock time Tk.
  • According to this variant, the control procedure comprises calculating the updated value Qpfr new for said fluid removal rate Qpfr at check point Ti comprised between a start time Tk and an end time Tk+1 according to the formula:

  • Q pfr new=[(T k+1 −T kQ pfr set −V pfr(0)](T k+1 −T i)   (7)
  • where:
    • Qpfr set is the set value for fluid removal rate;
    • Vpfr(0) is the value of fluid removed from patient over time window running from clock time Tk to check point (Ti);
    • Tk+1−Tk matches with Tretro+Tprosp;
    • Tk+1−Ti matches with Tprosp;
  • Applying the above algorithm (again refer to FIG. 7) and assuming that:
      • the operator initially sets a Qpfr set=100 ml/h;
      • Predefined clock times: 6:00; 13:00; 20:00;
      • Check time Ti: 11:12;
      • The fluid actually removed over [6:00; 11:12] as measured by scale 33 (of course in case the apparatuses of FIGS. 1 and 2 would be used then information from all scales would be received by the control unit) is Vpfr(k−1)=508 ml;
      • No bag change expected before next predefined clock time T2=13:00;
      • Mean time for changing a bag: Tchange bag=100 s;
      • Alarm down time coefficient: Kalarm=1.5%, the effective run time Teff of ‘prospective’ time window [11:12; 13:00] is:

  • T eff=(13.0−11.2)−0.015·.(13.0−11.2)−0. (100/3600)=1.773 h
  • Then, applying formula (7) above:

  • Q pfr new=[(13.0−6.0).·100−508]/1.773=108.3 ml/h
  • Thus, the control unit 10 will control the pump 17 based on the new calculated value of 108.3 ml/h from the 11:12 check point in order to achieve the desired patient fluid removal by 13.00.
  • Safety Features
  • The apparatus described above may include one or more of the following safety features.
  • For instance safety features below disclosed may play an important role after a therapy interruption of several tens of minutes, e.g. change of the disposable tubing or substitution of filter set associated with the apparatus, temporary patient disconnection due to any reason. These situations may lead to relatively high Qpfr_new values which if actuated with no safety checks might lead to problems for the treated patient.
  • The control procedure executed by the control unit 10 may include a step of requesting the user, for instance via the user interface 12, to confirm that the calculated updated value Qpfr new for said fluid removal rate Qpfr is acceptable before using it for controlling the ultrafiltration actuator. In practice the control unit would in this case wait for a user confirmation before actually using the calculated updated value Qpfr new for controlling pump 17.
  • The control procedure may also include comparing the calculated updated value Qpfr new for said fluid removal rate (Qpfr) against a maximum threshold value before using it for controlling the ultrafiltration actuator. In practice in case the calculate value would be too high either a lower value is used or an alarm condition is generated or a warning signal sent to the operator e.g. via user interface 12.
  • The control procedure may comprise executing one or more of the following further safety checks:
      • comparing the ratio between the calculated updated value and the set value for the patient fluid removal rate with a first boundary condition (typically to ±30%),
      • comparing the absolute difference between the calculated updated value and the set value for the patient fluid removal rate with a second boundary condition (typically by ±100 ml/h),
      • comparing the absolute difference between the calculated updated value and the set value for the patient fluid removal rate as a function of patient body weight with a third boundary condition (typically by 0.1 ml/min/kg).
  • If a prefixed number of said checks is positively passed, for instance if all checks are passed, the update value Qpfr new is used for controlling the ultrafiltration actuator.
  • Note that the control unit is may also be configured for allowing setting of one or more boundary conditions in order to customize the apparatus to specific needs or patients.
  • Control Unit
  • As already indicated the apparatus according to the invention makes use of at least one control unit. This control unit may comprise a digital processor (CPU) with memory (or memories), an analogical type circuit, or a combination of one or more digital processing units with one or more analogical processing circuits. In the present description and in the claims it is indicated that the control unit is “configured” or “programmed” to execute certain steps: this may be achieved in practice by any means which allow configuring or programming the control unit. For instance, in case of a control unit comprising one or more CPUs, one or more programs are stored in an appropriate memory: the program or programs containing instructions which, when executed by the control unit, cause the control unit to execute the steps described or claimed in connection with the control unit. Alternatively, if the control unit is of an analogical type, then the circuitry of the control unit is designed to include circuitry configured, in use, to process electric signals such as to execute the control unit steps herein disclosed.

Claims (29)

1-26. (canceled)
27. A process of controlling an apparatus for extracorporeal treatment of blood, the apparatus being of the type comprising: a filtration unit having a primary chamber and a secondary chamber separated by a semi-permeable membrane; a blood withdrawal line connected to an inlet of the primary chamber, and a blood return line connected to an outlet of the primary chamber said blood lines being designed to be connected to a patient cardiovascular system; a blood pump for controlling the flow of blood through the blood lines; an effluent fluid line connected to an outlet of the secondary chamber; an ultrafiltration actuator connected to the effluent fluid line and configured to cause a transfer of fluid from the primary to the secondary chamber, and
a control unit configured to execute a control procedure comprising:
controlling the ultrafiltration actuator based on a set value for patient fluid removal rate, said set value being a desired value for the rate of fluid removal from the patient,
executing at check points during patient treatment a control procedure comprising:
receiving one check information selected in the group of:
a value of fluid removed from the patient over a time period preceding a check point,
an effective time portion, of a time period preceding a check point, during which said ultrafiltration actuator is operated,
a down time portion, of a time period preceding a check point, during which said ultrafiltration actuator is not operated,
calculating an updated value for said fluid removal rate as a function of said set value for a fluid removal rate and of said check information.
28. A process according to claim 27 wherein the control procedure further comprises, after calculation of said updated value, controlling the ultrafiltration actuator after the check point as a function of said updated value for the fluid removal rate.
29. (canceled)
30. A process according to claim 27, wherein the control procedure comprises re-executing said control procedure at a plurality of check points during patient treatment, said plurality of check points comprising one or more in the group of:
check points at regular intervals,
periodic check points,
check points triggered by specific setting of a new set value for patient fluid removal rate,
check points triggered by a stop in the ultrafiltration actuator,
check points triggered by each time a flow rate setting is changed.
31. A process according to claim 27 wherein the control procedure comprises:
determining a value of the fluid removed from the patient over a time period preceding a check point;
determining a value of fluid to be removed from the patient over a time period following the check point in order to achieve the set value for fluid removal rate over the sum of the time period preceding check point and of the time period following the check point;
calculating the updated value for said fluid removal rate based on said set value for a fluid removal rate, on said value of fluid to be removed from the patient over the time period following the check point and on the duration the time period following the check point.
32. A process according to claim 31 wherein the control procedure comprises calculating the updated value for said fluid removal rate at check point according to the formula:

Q pfr new=[(T retro +T prospQ pfr set V pfr removed ]/T prosp
where:
Qpfr new is the calculated updated value for said fluid removal rate;
Qpfr set is the set value for fluid removal rate;
Vpfr removed is the value of the fluid removed from the patient over time period Tretro preceding a check point;
Tretro is a time period preceding the check point;
Tprosp is a time period following the check point;
(Tretro+Tprosp) is the sum of the time period (Tretro) preceding the check point and of the time period (Tprosp) following the check point.
33. (canceled)
34. A process according to claim 27 wherein the control procedure comprises calculating the updated value for said fluid removal rate at a check point comprised between a start time and an end time according to the formula:

Q pfr new=(ΔT·Q pfr set −V pfr(0))/[(T 00+(k+1)·ΔT)−T i]
or

Q pfr new=(2·ΔT·Q pfr set −V pfr(0) −V pfr(k−1))/[(T 00+(k+1)·ΔT)−Ti]
where:
Qpfr new is the updated value for fluid removal rate;
Qpfr set is the set value for fluid removal rate;
(T00+k·ΔT) is the start time;
T00+(k+1)·ΔT is the end time;
Ti is the check point;
Vpfr(0) is the value of the fluid removed from the patient over time window running from start time (T00+k·ΔT) to check point (Ti);
Vpfr(k-1) is the value of the fluid removed from the patient over time window running from start time (T00+(k−1)·ΔT) to end time (T00+k·ΔT);
[(T00+(k+1)·ΔT)−Ti] is the duration of time period following the check point (T1);
ΔT is a reference time interval of prefixed duration.
35. A process according to claim 27 wherein the control procedure comprises:
determining an effective portion of said the time period following the check point, during which it is forecasted that the ultrafiltration actuator will be actually pulling fluid from the primary into the secondary chamber;
calculating the updated value for said fluid removal rate using said effective portion in place of the duration the time period following the check point.
36. A process according to claim 35 wherein the effective portion is calculated by reducing the duration of said the time period following check point by a quantity linked to one or more of:
number of bag changes expected in the next time period;
down times caused by alarm conditions;
down times caused by alarm conditions if the duration of the time period following the check point is greater than a prefixed duration.
37-41. (canceled)
42. A process according to claim 27 wherein the control procedure comprises comparing the calculated updated value for said fluid removal rate against a maximum threshold value before using it for controlling the ultrafiltration actuator.
43. A process according to claim 27 wherein the control procedure comprises executing one or more of the following safety checks:
comparing the ratio between the calculated updated value and the set value for the patient fluid removal rate with a first boundary condition,
comparing the absolute difference between the calculated updated value and the set value for the patient fluid removal rate with a second boundary condition,
comparing the absolute difference between the calculated updated value and the set value for the patient fluid removal rate as a function of patient body weight with a third boundary condition,
wherein the control procedure comprises verifying that a prefixed number of said checks is positively passed before using the update value for controlling the ultrafiltration actuator.
44-47. (canceled)
48. An apparatus for extracorporeal treatment of blood comprising:
a filtration unit having a primary chamber and a secondary chamber separated by a semi-permeable membrane;
a blood withdrawal line connected to an inlet of the primary chamber, and a blood return line connected to an outlet of the primary chamber said blood lines being designed to be connected to a patient cardiovascular system;
a blood pump for controlling the flow of blood through the blood lines;
an effluent fluid line connected to an outlet of the secondary chamber;
an ultrafiltration actuator connected to the effluent fluid line and configured to cause a transfer of fluid from the primary to the secondary chamber; and
a control unit configured to control the ultrafiltration actuator based on a set value for patient fluid removal rate, said set value being a desired value for the rate of fluid removal from the patient, wherein the control unit is configured to execute at check points during patient treatment a control procedure comprising:
receiving one check information selected in the group of:
a value of fluid removed from the patient over a time period preceding a check point,
an effective time portion, of a time period preceding a check point, during which said ultrafiltration actuator is operated,
a down time portion, of a time period preceding a check point, during which said ultrafiltration actuator is not operated,
calculating an updated value for said fluid removal rate as a function of said set value for a fluid removal rate and of said check information.
49. (canceled)
50. Apparatus according to claim 48 wherein the control procedure further comprises controlling the ultrafiltration actuator, after the check point and until a subsequent check point as a function of said updated value for the fluid removal rate.
51. Apparatus according to claim 48 wherein the control unit is configured for re-executing said control procedure at a plurality of check points during patient treatment, said plurality of check points comprising one or more in the group of:
check points at regular intervals,
periodic check points,
check points triggered by specific setting of a new set value for patient fluid removal rate,
check points triggered by a stop in the ultrafiltration actuator,
check points triggered by each time a flow rate setting is changed.
52. The apparatus of claim 48 wherein the control procedure comprises:
determining a value of the fluid removed from the patient over a time period preceding a check point;
determining a value of fluid to be removed from the patient over a time period following the check point in order to achieve the set value for fluid removal rate over the sum of the time period preceding check point and of the time period following the check point;
calculating the updated value for said fluid removal rate based on said set value for a fluid removal rate, on said value of fluid to be removed from the patient over the time period following the check point and on the duration the time period following the check point.
53. The apparatus of claim 52 wherein the control procedure comprises calculating the updated value for said fluid removal rate at check point according to the formula:

Q pfr new=[(T retro +T prospQ pfr set −V pfr removed ]/T prosp
where:
Qpfr new is the calculated updated value for said fluid removal rate;
Qpfr set is the set value for fluid removal rate;
Vpfr removed is the value of the fluid removed from the patient over time period (Tretro) preceding a check point;
Tretro is a time period preceding check point;
Tprosp is a time period following the check point;
(Tretro+Tprosp) is the sum of the time period (Tretro) preceding the check point and of the time period (Tprosp) following the check point.
54. (canceled)
55. The apparatus of claim 48 wherein the control procedure comprises calculating the updated value for said fluid removal rate at check point comprised between a start time and an end time according to the formula:

Q pfr new=(ΔT·Q pfr set −V pfr(0))/[(T 00+(k+1)·ΔT)−T i]
or

Q pfr new=(2·ΔT·Q pfr set −V pfr(0) −V pfr(k−1))/[(T 00+(k+1)·ΔT)−T i]
where:
Qpfr new is the updated value for fluid removal rate;
Qpfr set is the set value for fluid removal rate;
(T00+k·ΔT) is the start time;
T00+(k+1)·ΔT is the end time;
Ti is the check point;
Vpfr(0) is the value of the fluid removed from the patient over time window running from start time (T00+k·ΔT) to check point (Ti);
Vpfr(k−1) is the value of the fluid removed from the patient over time window running from start time (T00+(k−1)·ΔT) to end time (T00+k·ΔT);
[(T00+(k+1)·ΔT)−Ti] is the duration of time period following the check point (Ti);
ΔT is a reference time interval of prefixed duration.
56. The apparatus according to claim 48 wherein, the control procedure comprises:
determining an effective portion of said the time period following the check point, during which it is forecasted that the ultrafiltration actuator will be actually pulling fluid from the primary into the secondary chamber;
calculating the updated value for said fluid removal rate using said effective portion (Teff) in place of the duration the time period following the check point;
wherein the effective portion is calculated reducing the duration of said the time period following the check point by a first quantity linked to the number of bag changes expected in the next time period and/or by a second quantity linked to down times caused by alarm conditions.
57-60. (canceled)
61. The apparatus according to claim 48 wherein the control procedure comprises:
requesting the user, via a user interface, to confirm that the calculated updated value for said fluid removal rate is acceptable before using it for controlling the ultrafiltration actuator, and
comparing the calculated updated value for said fluid removal rate against a maximum threshold value before using it for controlling the ultrafiltration actuator.
62. (canceled)
63. The apparatus according to claim 48 wherein the control procedure comprises executing one or more of the following safety checks:
comparing the ratio between the calculated updated value and the set value for the patient fluid removal rate with a first boundary condition,
comparing the absolute difference between the calculated updated value and the set value for the patient fluid removal rate with a second boundary condition,
comparing the absolute difference between the calculated updated value and the set value for the patient fluid removal rate as a function of patient body weight with a third boundary condition,
wherein the control procedure comprises verifying that a prefixed number of said checks is positively passed before using the update value for controlling the ultrafiltration actuator.
64-65. (canceled)
US14/388,295 2012-03-28 2013-03-22 Apparatus for extracorporeal treatment of blood Abandoned US20150060362A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
US14/388,295 US20150060362A1 (en) 2012-03-28 2013-03-22 Apparatus for extracorporeal treatment of blood
US15/240,231 US10258726B2 (en) 2012-03-28 2016-08-18 Process of controlling an apparatus for extracorporeal treatment of blood

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201261616519P 2012-03-28 2012-03-28
EP12002252. 2012-03-28
EP12002252.0A EP2644215B1 (en) 2012-03-28 2012-03-28 Apparatus for extracorporeal treatment of blood
PCT/IB2013/052275 WO2013144793A1 (en) 2012-03-28 2013-03-22 Apparatus for extracorporeal treatment of blood
US14/388,295 US20150060362A1 (en) 2012-03-28 2013-03-22 Apparatus for extracorporeal treatment of blood

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2013/052275 A-371-Of-International WO2013144793A1 (en) 2012-03-28 2013-03-22 Apparatus for extracorporeal treatment of blood

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US15/240,231 Division US10258726B2 (en) 2012-03-28 2016-08-18 Process of controlling an apparatus for extracorporeal treatment of blood

Publications (1)

Publication Number Publication Date
US20150060362A1 true US20150060362A1 (en) 2015-03-05

Family

ID=45992006

Family Applications (3)

Application Number Title Priority Date Filing Date
US14/388,295 Abandoned US20150060362A1 (en) 2012-03-28 2013-03-22 Apparatus for extracorporeal treatment of blood
US15/240,231 Active 2033-11-30 US10258726B2 (en) 2012-03-28 2016-08-18 Process of controlling an apparatus for extracorporeal treatment of blood
US16/295,878 Pending US20190201605A1 (en) 2012-03-28 2019-03-07 Apparatus for extracorporeal treatment of blood

Family Applications After (2)

Application Number Title Priority Date Filing Date
US15/240,231 Active 2033-11-30 US10258726B2 (en) 2012-03-28 2016-08-18 Process of controlling an apparatus for extracorporeal treatment of blood
US16/295,878 Pending US20190201605A1 (en) 2012-03-28 2019-03-07 Apparatus for extracorporeal treatment of blood

Country Status (8)

Country Link
US (3) US20150060362A1 (en)
EP (1) EP2644215B1 (en)
CN (1) CN104203306B (en)
AU (1) AU2013202726B2 (en)
CA (1) CA2866497C (en)
ES (1) ES2532081T3 (en)
PL (1) PL2644215T3 (en)
WO (1) WO2013144793A1 (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9486590B2 (en) 2014-09-29 2016-11-08 Fenwal, Inc. Automatic purging of air from a fluid processing system
US9498567B2 (en) 2014-09-29 2016-11-22 Fenwal, Inc. Systems and methods for controlling the return phase of a blood separation procedure
EP3479855A1 (en) * 2017-11-07 2019-05-08 B. Braun Avitum AG Device for extracorporeal blood treatment with gravimetric balancing and ultrafiltration
WO2019219442A1 (en) * 2018-05-17 2019-11-21 Gambro Lundia Ab Calculation of the patient fluid removal rate to compensate for the volume of fluid not removed because of machine down times

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3015123B1 (en) * 2014-10-29 2017-03-22 B. Braun Avitum AG Acute renal replacement therapy apparatus
WO2017084682A1 (en) 2015-11-20 2017-05-26 Hepa Wash Gmbh Method for extracorporeal carbon dioxide removal
WO2017084683A1 (en) 2015-11-20 2017-05-26 Hepa Wash Gmbh Method for extracorporeal lung support
RU2729725C2 (en) * 2016-03-14 2020-08-11 Хепа Уош Гмбх Systems or devices and methods of dialysis
CA3075994A1 (en) 2017-05-22 2018-11-29 Advitos Gmbh Methods and systems for removing carbon dioxide
US10881347B2 (en) 2017-12-29 2021-01-05 Fresenius Medical Care Holdings, Inc. Closed loop dialysis treatment using adaptive ultrafiltration rates
DE102018106254A1 (en) 2018-03-16 2019-09-19 Fresenius Medical Care Deutschland Gmbh A method of adjusting a control device of a blood treatment device, and devices
EP3892313B1 (en) * 2020-04-09 2023-01-11 Gambro Lundia AB Apparatus for extracorporeal blood treatment
US11865302B1 (en) 2023-02-20 2024-01-09 Nuwellis, Inc. Extracorporeal blood filtering machine and methods

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998050091A1 (en) * 1997-05-07 1998-11-12 Infomed S.A. Method for controlling a blood purifying device

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1255260B (en) * 1991-07-16 1995-10-20 Hospal Dasco Spa METHOD OF SURVEILLANCE OF A THERAPY IN A DIALYTIC TREATMENT.
US5211849B1 (en) * 1991-10-11 1997-05-27 Childrens Hosp Medical Center Hemofiltration system and method
DE60334551D1 (en) * 2002-08-08 2010-11-25 Asahi Kasei Medical Co Ltd BLOOD CLEANING DEVICE
ATE298595T1 (en) * 2002-09-05 2005-07-15 Gambro Lundia Ab CONTROL FOR A BLOOD TREATMENT DEVICE
FR2852515B1 (en) * 2003-03-17 2005-11-18 DEVICE AND METHOD FOR BLOOD TREATMENT WITH SELECTIVE EXTRACTION OF SOLUTES
US7291269B2 (en) 2003-03-17 2007-11-06 Gambro Lundia Ab Apparatus and process for extracorporeal treatment of blood with selective extraction of solutes
US7588722B2 (en) * 2003-06-25 2009-09-15 Gambro Lundia Ab Extracorporeal treatment device with automatic emptying of waste bag
WO2005107833A1 (en) * 2004-05-07 2005-11-17 Gambro Lundia Ab Blood treatment equipment, method and software program for controlling infusion.
EP1784248B1 (en) * 2004-06-09 2014-07-30 Renal Solutions, Inc. Dialysis system
ITMO20040191A1 (en) * 2004-07-23 2004-10-23 Gambro Lundia Ab MACHINE AND METHOD FOR EXTRA-BODY BLOOD TREATMENT.
CN2922917Y (en) * 2005-12-27 2007-07-18 重庆圣德利医疗器械研究有限公司 Volume super-filtering control system for blood dialysis
US8187250B2 (en) * 2006-01-30 2012-05-29 The Regents Of The University Of California Peritoneal dialysis methods and apparatus
CN100493632C (en) * 2006-08-25 2009-06-03 重庆山外山科技有限公司 Weighing balancing system for blood purification
US8246566B2 (en) * 2006-12-22 2012-08-21 Baxter International Inc. Total fluid loss control system
EP4309691A2 (en) * 2007-02-27 2024-01-24 DEKA Products Limited Partnership Hemodialysis systems
US8858787B2 (en) * 2007-10-22 2014-10-14 Baxter International Inc. Dialysis system having non-invasive fluid velocity sensing
IT1391555B1 (en) * 2008-07-16 2012-01-11 Gambro Lundia Ab EXTRACORPOREO BLOOD TREATMENT SYSTEM
CN101347644B (en) * 2008-09-01 2010-06-09 中国人民解放军海军总医院 Portable continuous renal replacement therapy equipment
CN101708347B (en) * 2009-03-11 2013-02-20 重庆多泰医用设备有限公司 Hemodialysis system for controlling electric conduction and ultra-filtration by weighing
CN201692385U (en) * 2009-05-08 2011-01-05 彭罗民 Novel automatic liquid distribution capacity-balanced ultrafiltration device of hemodialysis machine
TWM419385U (en) 2011-07-22 2011-12-21 Cooler Master Co Ltd Having inequality cross-section heat pipe and heat dissipation device includes the heat pipe

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998050091A1 (en) * 1997-05-07 1998-11-12 Infomed S.A. Method for controlling a blood purifying device

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9486590B2 (en) 2014-09-29 2016-11-08 Fenwal, Inc. Automatic purging of air from a fluid processing system
US9498567B2 (en) 2014-09-29 2016-11-22 Fenwal, Inc. Systems and methods for controlling the return phase of a blood separation procedure
EP3479855A1 (en) * 2017-11-07 2019-05-08 B. Braun Avitum AG Device for extracorporeal blood treatment with gravimetric balancing and ultrafiltration
DE102017125962A1 (en) * 2017-11-07 2019-05-09 B. Braun Avitum Ag Device for extracorporeal blood treatment with gravimetric balancing and possibility for ultrafiltration
US10857279B2 (en) 2017-11-07 2020-12-08 B. Braun Avitum Ag Device for extracorporeal blood treatment with gravimetric balancing and possibility of ultrafiltration
WO2019219442A1 (en) * 2018-05-17 2019-11-21 Gambro Lundia Ab Calculation of the patient fluid removal rate to compensate for the volume of fluid not removed because of machine down times
CN112135646A (en) * 2018-05-17 2020-12-25 甘布罗伦迪亚股份公司 Calculation of patient fluid withdrawal rate to compensate for fluid volume not withdrawn due to machine downtime
JP2021528122A (en) * 2018-05-17 2021-10-21 ガンブロ・ルンディア・エービーGambro Lundia Ab Calculation of patient fluid removal rate to compensate for the amount of fluid not removed due to equipment downtime
JP7451426B2 (en) 2018-05-17 2024-03-18 ガンブロ・ルンディア・エービー Calculation of patient fluid removal rate to compensate for the amount of fluid not removed due to equipment downtime

Also Published As

Publication number Publication date
WO2013144793A1 (en) 2013-10-03
CA2866497A1 (en) 2013-10-03
US20160354528A1 (en) 2016-12-08
US20190201605A1 (en) 2019-07-04
EP2644215B1 (en) 2014-12-17
US10258726B2 (en) 2019-04-16
CN104203306A (en) 2014-12-10
AU2013202726B2 (en) 2015-05-07
EP2644215A1 (en) 2013-10-02
CA2866497C (en) 2019-12-03
AU2013202726A1 (en) 2013-10-17
ES2532081T3 (en) 2015-03-24
PL2644215T3 (en) 2015-04-30
CN104203306B (en) 2017-03-01

Similar Documents

Publication Publication Date Title
US10258726B2 (en) Process of controlling an apparatus for extracorporeal treatment of blood
US20200345922A1 (en) Apparatus for extracorporeal treatment of blood
US11207451B2 (en) Medical apparatus for extracorporeal treatment of fluid and a process of calculating set flow rates in a medical apparatus for delivery or collection of fluids
US20210106738A1 (en) Apparatus for extracorporeal treatment of blood including calculation of pre-blood pump infusion flow rate
EP2121074B1 (en) Total fluid loss control system
US10485912B2 (en) Extracorporeal blood treatment system for individualized treatment
US11857711B2 (en) Method for setting a control device or a closed-loop control device of a blood treatment apparatus, and devices

Legal Events

Date Code Title Description
AS Assignment

Owner name: GAMBRO LUNDIA AB, SWEDEN

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:POUCHOULIN, DOMINIQUE;REEL/FRAME:034229/0575

Effective date: 20141002

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION